株探米国株
英語
エドガーで原本を確認する
--12-31false0000006176Q1http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpensefive yearsfive yearssix yearsSix yearshttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrentthree yearshttp://fasb.org/srt/2024#ChiefExecutiveOfficerMember0000006176ap:AluminumPurchasesMember2025-03-310000006176us-gaap:OperatingSegmentsMemberap:ForgedAndCastMillRollsMember2024-01-012024-03-310000006176ap:IndustrialRevenueBondsMemberap:TaxableIndustrialRevenueBondMember2025-03-310000006176country:US2025-01-012025-03-310000006176us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310000006176ap:CentrifugalPumpsMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000006176ap:IndustrialRevenueBondsMember2025-03-310000006176ap:SaleAndLeasebackFinancingObligationsMember2024-01-012024-03-310000006176us-gaap:MachineryAndEquipmentMember2024-12-310000006176ap:CentrifugalPumpsMemberus-gaap:OperatingSegmentsMember2025-01-012025-03-310000006176us-gaap:SegmentContinuingOperationsMembercountry:US2024-12-310000006176us-gaap:RelatedPartyMember2024-01-012024-03-310000006176us-gaap:AdditionalPaidInCapitalMember2024-03-310000006176us-gaap:NaturalGasGatheringTransportationMarketingAndProcessingMember2025-01-012025-03-310000006176ap:AluminumPurchasesMember2024-03-310000006176ap:IncentivePlanMembersrt:MaximumMember2025-01-012025-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2024-12-310000006176us-gaap:RevolvingCreditFacilityMember2024-01-012024-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2025-03-310000006176us-gaap:CommonStockMember2025-01-012025-03-310000006176ap:NoncurrentLiabilityMember2025-01-012025-03-310000006176us-gaap:RevolvingCreditFacilityMember2024-12-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:FuturesContractsCopperAndAluminumMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310000006176ap:BuildingsAndLeaseholdImprovementsMember2025-03-310000006176us-gaap:BaseRateMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176us-gaap:RelatedPartyMember2024-12-310000006176us-gaap:RelatedPartyMemberap:ATRMember2024-01-012024-03-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-03-310000006176country:US2024-01-012024-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-310000006176us-gaap:NoncontrollingInterestMember2024-01-012024-03-310000006176srt:MaximumMember2025-01-012025-03-310000006176us-gaap:OperatingSegmentsMemberap:ForgedAndCastMillRollsMember2025-01-012025-03-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:CorporateNonSegmentMember2025-03-310000006176ap:AluminumPurchasesMember2025-01-012025-03-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2023-12-310000006176ap:NonMesotheliomaClaimsMember2024-01-012024-03-310000006176us-gaap:CashFlowHedgingMemberap:AluminumPurchasesMember2024-03-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2023-12-310000006176us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2024-12-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-12-310000006176us-gaap:NoncontrollingInterestMember2023-12-310000006176us-gaap:RetainedEarningsMember2023-12-310000006176us-gaap:RevolvingCreditFacilityMember2021-06-290000006176us-gaap:RelatedPartyMember2025-01-012025-03-310000006176ap:AsbestosClaimsMember2024-01-012024-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:ForeignCurrencyPurchasesContractsMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-03-310000006176ap:EquipmentFinancingFacilityMember2025-01-012025-03-310000006176us-gaap:OperatingSegmentsMember2025-01-012025-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310000006176us-gaap:CapitalAdditionsMemberap:SaleAndLeasebackFinancingObligationsMember2022-08-012022-08-310000006176us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000006176us-gaap:NoncontrollingInterestMember2025-01-012025-03-310000006176us-gaap:NoncontrollingInterestMember2025-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310000006176us-gaap:NoncontrollingInterestMember2024-03-310000006176us-gaap:RetainedEarningsMember2025-03-310000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310000006176ap:FuturesContractsCopperAndAluminumMember2023-12-310000006176us-gaap:CashFlowHedgingMemberap:AluminumPurchasesMember2025-03-310000006176us-gaap:CorporateNonSegmentMember2025-01-012025-03-310000006176us-gaap:OperatingSegmentsMemberap:HeatExchangeCoilsMember2025-01-012025-03-310000006176ap:EuropeanCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2021-06-290000006176us-gaap:ConstructionInProgressMember2025-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2024-01-012024-03-310000006176us-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2024-01-012024-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-03-310000006176ap:IndustrialRevenueBondsMemberap:TaxExemptIndustrialRevenueBondTwoMember2025-01-012025-03-310000006176us-gaap:RetainedEarningsMember2024-03-310000006176ap:SeriesAWarrantsMember2025-01-012025-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-310000006176us-gaap:ConstructionInProgressMember2024-12-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:FuturesContractsCopperAndAluminumMember2025-03-310000006176us-gaap:CapitalAdditionsMember2025-01-012025-03-310000006176ap:EquipmentFinancingFacilityMember2024-12-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310000006176us-gaap:PensionPlansDefinedBenefitMemberus-gaap:NonqualifiedPlanMembercountry:US2024-01-012024-03-310000006176us-gaap:OperatingSegmentsMemberap:AirHandlingSystemsMember2025-01-012025-03-310000006176us-gaap:AdditionalPaidInCapitalMember2023-12-310000006176country:GBap:DefinedContributionPlanMember2025-01-012025-03-3100000061762023-12-3100000061762025-05-082025-05-080000006176us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-03-310000006176us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2024-12-310000006176us-gaap:CommonStockMember2024-03-310000006176us-gaap:OperatingSegmentsMemberap:ForgedEngineeredProductsMember2025-01-012025-03-310000006176ap:DefinedContributionPlanMembercountry:US2025-01-012025-03-310000006176ap:SaleAndLeasebackFinancingObligationsMember2024-12-310000006176ap:DefinedContributionPlanMembercountry:US2024-01-012024-03-310000006176us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2025-01-012025-03-310000006176us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176ap:FuturesContractsCopperAndAluminumMember2024-01-012024-03-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2024-12-310000006176ap:SeriesAWarrantsMember2024-12-310000006176ap:EuropeanCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2025-03-310000006176us-gaap:OtherNoncurrentAssetsMemberus-gaap:InvestmentsMember2024-12-310000006176ap:AsbestosClaimsMember2023-12-310000006176ap:SeriesAWarrantsMember2025-03-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2025-03-310000006176ap:EquipmentFinancingFacilityMemberap:TermNotesMember2025-01-012025-03-310000006176us-gaap:SalesRevenueNetMembersrt:MaximumMemberus-gaap:GeographicConcentrationRiskMember2025-01-012025-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2024-03-310000006176us-gaap:SegmentContinuingOperationsMembercountry:US2025-03-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-310000006176us-gaap:RelatedPartyMemberap:ATRMember2025-01-012025-03-310000006176ap:NaturalGasUsageMember2025-03-310000006176ap:EquipmentFinancingFacilityMember2022-09-292022-09-290000006176us-gaap:OperatingSegmentsMemberap:ForgedAndCastEngineeredProductsMember2025-01-012025-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:ForeignCurrencyPurchasesContractsMember2025-03-310000006176us-gaap:SalesRevenueNetMembersrt:MaximumMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310000006176ap:NaturalGasUsageMember2024-03-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:OperatingSegmentsMemberap:AirAndLiquidProcessingMember2025-03-310000006176us-gaap:CommonStockMember2024-12-310000006176ap:FuturesContractsCopperAndAluminumMember2024-03-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:OperatingSegmentsMemberap:AirAndLiquidProcessingMember2024-12-310000006176ap:CopperPurchasesMember2024-01-012024-03-310000006176country:GBap:DefinedContributionPlanMember2024-01-012024-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2025-01-012025-03-310000006176ap:EquipmentFinancingFacilityMember2025-03-3100000061762025-05-080000006176ap:ATRMember2025-01-012025-03-310000006176ap:IncentivePlanMemberus-gaap:SubsequentEventMembersrt:MaximumMember2025-05-080000006176us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2024-01-012024-03-310000006176us-gaap:OperatingSegmentsMemberap:AirAndLiquidProcessingMember2024-01-012024-03-310000006176us-gaap:CustomerRelationshipsMember2025-03-310000006176us-gaap:AdditionalPaidInCapitalMember2024-12-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-3100000061762024-01-012024-03-310000006176ap:EquipmentFinancingFacilityMembersrt:MinimumMemberap:TermNotesMember2025-01-012025-03-310000006176us-gaap:CapitalAdditionsMemberap:SaleAndLeasebackFinancingObligationsMember2023-06-012023-06-300000006176ap:FuturesContractsCopperAndAluminumMember2025-01-012025-03-3100000061762024-12-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:CorporateNonSegmentMember2024-12-310000006176ap:IncentivePlanMembersrt:MaximumMember2025-03-310000006176ap:SaleAndLeasebackFinancingObligationsMember2025-03-3100000061762025-01-012025-03-310000006176ap:SeriesAWarrantsMember2020-09-300000006176srt:MinimumMemberap:ATRMember2025-01-012025-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2024-12-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000006176us-gaap:CommonStockMember2025-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2024-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2025-03-310000006176ap:AsbestosClaimsMember2024-03-310000006176ap:NaturalGasUsageMember2025-01-012025-03-310000006176us-gaap:SegmentContinuingOperationsMember2025-03-310000006176us-gaap:LetterOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-06-290000006176ap:ATRMember2025-01-012025-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-03-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2025-01-012025-03-310000006176ap:ElectricityUsageMember2025-01-012025-03-310000006176us-gaap:RetainedEarningsMember2024-01-012024-03-310000006176ap:MesotheliomaClaimMember2024-01-012024-03-310000006176ap:ElectricityUsageMember2025-03-310000006176ap:SaleAndLeasebackFinancingObligationsMembersrt:MaximumMember2025-01-012025-03-310000006176us-gaap:AdditionalPaidInCapitalMember2025-03-310000006176ap:IndustrialRevenueBondsMemberap:TaxableIndustrialRevenueBondMember2025-01-012025-03-310000006176us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2023-12-310000006176us-gaap:PensionPlansDefinedBenefitMemberus-gaap:ForeignPlanMember2024-01-012024-03-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2024-01-012024-03-310000006176us-gaap:RelatedPartyMemberap:ATRMember2024-12-310000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310000006176ap:AsbestosClaimsMember2024-12-310000006176ap:IndustrialRevenueBondsMemberap:TaxExemptIndustrialRevenueBondTwoMember2024-01-012024-03-310000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000006176us-gaap:AociAttributableToNoncontrollingInterestMember2024-03-310000006176us-gaap:LandAndLandImprovementsMember2024-12-310000006176ap:MesotheliomaClaimMember2025-01-012025-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310000006176ap:UnionElectricSteelUKLimitedMember2025-03-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2024-01-012024-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:AccumulatedAmortizationOfUnrecognizedEmployeeBenefitCostsMember2024-01-012024-03-310000006176ap:SaleAndLeasebackFinancingObligationsMember2022-10-140000006176ap:UnionElectricSteelDomesticMemberap:ConstructionInProcessMachineryAndEquipmentOrBuildingsMember2025-01-012025-03-310000006176ap:ChinaJointVentureMember2025-01-012025-03-310000006176ap:ATRMember2024-01-012024-03-310000006176ap:ElectricityUsageMember2024-03-310000006176us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000006176ap:ATRMember2024-01-012024-03-310000006176us-gaap:RelatedPartyMember2025-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:AccumulatedAmortizationOfUnrecognizedEmployeeBenefitCostsMember2025-01-012025-03-310000006176us-gaap:RetainedEarningsMember2024-12-310000006176us-gaap:RevolvingCreditFacilityMember2025-03-310000006176ap:IndustrialRevenueBondsMemberap:TaxExemptIndustrialRevenueBondTwoMember2025-03-310000006176ap:EquipmentFinancingFacilityMemberap:TermNotesMember2024-01-012024-03-310000006176ap:IndustrialRevenueBondsMember2024-12-310000006176us-gaap:OperatingSegmentsMemberap:HeatExchangeCoilsMember2024-01-012024-03-310000006176us-gaap:RevolvingCreditFacilityMemberap:SeniorSecuredAssetBasedRevolvingCreditFacilityMember2021-06-290000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2023-12-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2024-03-310000006176us-gaap:DevelopedTechnologyRightsMember2025-03-310000006176us-gaap:CommonStockMemberap:SeriesAWarrantsMember2020-09-012020-09-300000006176us-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2025-03-310000006176ap:ForeignCurrencyPurchasesContractsMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2025-03-310000006176ap:BuildingsAndLeaseholdImprovementsMember2024-12-310000006176us-gaap:MachineryAndEquipmentMember2025-03-310000006176us-gaap:PensionPlansDefinedBenefitMemberus-gaap:NonqualifiedPlanMembercountry:US2025-01-012025-03-310000006176us-gaap:CustomerRelationshipsMember2024-12-310000006176us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2025-01-012025-03-310000006176us-gaap:OperatingSegmentsMember2024-01-012024-03-310000006176us-gaap:NoncontrollingInterestMember2024-12-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:OperatingSegmentsMemberap:ForgedAndCastEngineeredProductsMember2025-03-310000006176us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000006176us-gaap:PensionPlansDefinedBenefitMembercountry:US2025-01-012025-03-310000006176ap:CopperPurchasesMember2024-03-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000006176us-gaap:PensionPlansDefinedBenefitMembercountry:US2024-01-012024-03-310000006176us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberap:FuturesContractsCopperAndAluminumMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-03-310000006176us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2025-03-310000006176ap:ForgedAndCastEngineeredProductsMember2025-03-310000006176us-gaap:CommonStockMemberap:SeriesAWarrantsMember2020-09-300000006176ap:ForeignMember2024-01-012024-03-310000006176ap:AsbestosClaimsMember2025-01-012025-03-310000006176us-gaap:SegmentContinuingOperationsMemberap:ForeignMember2025-03-310000006176ap:AsbestosClaimsMember2025-03-310000006176ap:IndustrialRevenueBondsMember2025-01-012025-03-310000006176ap:IndustrialRevenueBondsMemberap:TaxableIndustrialRevenueBondMember2024-01-012024-03-310000006176us-gaap:SegmentContinuingOperationsMemberus-gaap:OperatingSegmentsMemberap:ForgedAndCastEngineeredProductsMember2024-12-310000006176ap:LandAndLandImprovementsAndBuildingsAndLeaseholdImprovementsMemberap:SaleAndLeasebackFinancingObligationsMember2025-03-310000006176ap:SaleAndLeasebackFinancingObligationsMember2025-01-012025-03-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000006176us-gaap:BaseRateMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2025-03-310000006176ap:EquipmentFinancingFacilityMember2022-09-290000006176srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2025-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-01-012025-03-310000006176ap:AluminumPurchasesMember2024-01-012024-03-310000006176us-gaap:DevelopedTechnologyRightsMember2024-12-310000006176us-gaap:SegmentContinuingOperationsMember2024-12-310000006176ap:AccumulatedOtherComprehensiveIncomeLossPlusOtherComprehensiveIncomeLossMember2025-01-012025-03-310000006176ap:EuropeanCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-12-310000006176us-gaap:LandAndLandImprovementsMember2025-03-310000006176ap:ForgedAndCastEngineeredProductsMember2024-12-310000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310000006176us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-01-012025-03-310000006176us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000006176us-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310000006176ap:FuturesContractsCopperAndAluminumMember2025-03-310000006176us-gaap:OperatingSegmentsMemberap:AirHandlingSystemsMember2024-01-012024-03-310000006176ap:SwedishCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2021-06-290000006176us-gaap:CashFlowHedgingMemberap:CopperPurchasesMember2024-03-3100000061762025-03-310000006176ap:ATRMemberap:MinorityShareholderLoanMember2024-03-310000006176us-gaap:OperatingSegmentsMemberap:ForgedAndCastEngineeredProductsMember2024-01-012024-03-310000006176us-gaap:CommonStockMember2023-12-310000006176us-gaap:NaturalGasGatheringTransportationMarketingAndProcessingMember2024-01-012024-03-310000006176ap:ForeignCurrencyPurchasesContractsMember2025-01-012025-03-310000006176ap:NonMesotheliomaClaimsMember2025-01-012025-03-310000006176us-gaap:OperatingSegmentsMemberap:ForgedEngineeredProductsMember2024-01-012024-03-310000006176us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2025-03-310000006176us-gaap:RetainedEarningsMember2025-01-012025-03-310000006176ap:ElectricityUsageMember2024-01-012024-03-310000006176ap:ATRMembersrt:MaximumMember2025-01-012025-03-310000006176us-gaap:RelatedPartyMemberap:ATRMember2025-03-310000006176ap:FuturesContractsCopperAndAluminumMember2024-12-310000006176us-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2024-12-310000006176us-gaap:OperatingSegmentsMemberap:AirAndLiquidProcessingMember2025-01-012025-03-310000006176ap:NaturalGasUsageMember2024-01-012024-03-310000006176us-gaap:MaterialReconcilingItemsMember2025-01-012025-03-310000006176us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000006176ap:AkersABMemberap:ATRMember2025-03-310000006176ap:ForeignMember2025-01-012025-03-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000006176ap:EquipmentFinancingFacilityMembersrt:MaximumMemberap:TermNotesMember2025-01-012025-03-310000006176us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000006176us-gaap:SegmentContinuingOperationsMemberap:ForeignMember2024-12-310000006176us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember2025-01-012025-03-310000006176us-gaap:OtherNoncurrentAssetsMemberus-gaap:InvestmentsMember2025-03-310000006176us-gaap:CommonStockMember2020-09-012020-09-3000000061762024-03-31xbrli:pureap:Customeriso4217:CNYap:Derivativeap:Segmentap:Companyiso4217:SEKxbrli:sharesiso4217:GBPap:Claimiso4217:USDxbrli:sharesap:Bondiso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2025

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

Commission File Number 1-898

AMPCO-PITTSBURGH CORPORATION

img139091968_0.jpg

 

 

Pennsylvania

25-1117717

(State of

Incorporation)

(I.R.S. Employer

Identification No.)

726 Bell Avenue, Suite 301

Carnegie, Pennsylvania 15106

(Address of principal executive offices)

(412) 456-4400

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1 par value

AP

New York Stock Exchange

Series A Warrants to purchase shares of Common Stock

AP WS

NYSE American Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 

 

 

 

 

 

Large accelerated filer

Accelerated filer

Emerging growth company

 

 

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

On May 8, 2025, 20,094,617 common shares were outstanding.

 


 

AMPCO-PITTSBURGH CORPORATION

INDEX

 

 

 

 

 

Page No.

Part I –

 

Financial Information:

 

 

 

 

 

 

 

 

 

 

 

Item 1 –

 

Financial Statements (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets – March 31, 2025 and December 31, 2024

 

3

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2025 and 2024

 

4

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) – Three Months Ended March 31, 2025 and 2024

 

 

5

 

 

 

 

Condensed Consolidated Statements of Shareholders’ Equity – Three Months Ended March 31, 2025 and 2024

 

6

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2025 and 2024

 

7

 

 

 

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

8

 

 

 

 

 

 

 

 

 

Item 2 –

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

22

 

 

 

 

 

 

 

 

 

Item 3 –

 

Quantitative and Qualitative Disclosures About Market Risk

 

31

 

 

 

 

 

 

 

 

 

Item 4 –

 

Controls and Procedures

 

31

 

 

 

 

 

 

 

Part II –

 

Other Information:

 

 

 

 

 

 

 

 

 

Item 1 –

 

Legal Proceedings

 

32

 

 

 

 

 

 

 

 

 

Item 1A –

 

Risk Factors

 

32

 

 

 

 

 

 

 

 

 

Item 5 –

 

Other Information

 

32

 

 

 

 

 

 

 

 

 

Item 6 –

 

Exhibits

 

33

 

 

 

 

 

 

 

Signatures

 

34

 

 

 

 

 

 

 

 

2


 

PART I – FINANCIAL INFORMATION

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except par value)

 

 

March 31, 2025

 

 

December 31, 2024

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

7,129

 

 

$

15,427

 

Trade receivables, less allowance for credit losses of $550 as of March 31, 2025 and $906 as of December 31, 2024

 

 

82,537

 

 

 

70,611

 

Trade receivables from related parties

 

 

2,380

 

 

 

1,839

 

Inventories

 

 

124,183

 

 

 

116,761

 

Insurance receivable – asbestos

 

 

15,000

 

 

 

15,000

 

Contract assets

 

 

5,489

 

 

 

8,486

 

Other current assets

 

 

9,772

 

 

 

8,663

 

Total current assets

 

 

246,490

 

 

 

236,787

 

Property, plant and equipment, net

 

 

147,208

 

 

 

148,056

 

Operating lease right-of-use assets

 

 

5,034

 

 

 

4,592

 

Insurance receivable – asbestos, less allowance for credit losses of $656 as of March 31, 2025
     and December 31, 2024

 

 

119,887

 

 

 

124,295

 

Deferred income tax assets

 

 

2,854

 

 

 

2,851

 

Intangible assets, net

 

 

4,494

 

 

 

4,255

 

Investments in joint ventures

 

 

2,175

 

 

 

2,175

 

Prepaid pensions

 

 

3,878

 

 

 

3,652

 

Other noncurrent assets

 

 

4,173

 

 

 

4,233

 

Total assets

 

$

536,193

 

 

$

530,896

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

41,342

 

 

$

36,310

 

Accounts payable to related parties

 

 

623

 

 

 

411

 

Accrued payrolls and employee benefits

 

 

17,465

 

 

 

17,104

 

Debt – current portion

 

 

12,210

 

 

 

12,186

 

Operating lease liabilities – current portion

 

 

968

 

 

 

878

 

Asbestos liability – current portion

 

 

24,000

 

 

 

24,000

 

Customer-related liabilities

 

 

26,736

 

 

 

25,608

 

Other current liabilities

 

 

9,233

 

 

 

8,719

 

Total current liabilities

 

 

132,577

 

 

 

125,216

 

Employee benefit obligations

 

 

27,088

 

 

 

28,204

 

Asbestos liability

 

 

176,317

 

 

 

183,092

 

Long-term debt

 

 

115,048

 

 

 

116,394

 

Noncurrent operating lease liabilities

 

 

4,066

 

 

 

3,714

 

Deferred income tax liabilities

 

 

463

 

 

 

450

 

Other noncurrent liabilities

 

 

2,964

 

 

 

2,735

 

Total liabilities

 

 

458,523

 

 

 

459,805

 

Commitments and contingent liabilities (Note 9)

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

Common stock – par value $1; authorized 40,000 shares; issued and outstanding
    19,980 shares as of March 31, 2025 and December 31, 2024

 

 

19,980

 

 

 

19,980

 

Additional paid-in capital

 

 

178,604

 

 

 

178,298

 

Retained deficit

 

 

(71,417

)

 

 

(72,559

)

Accumulated other comprehensive loss

 

 

(62,525

)

 

 

(66,836

)

Total Ampco-Pittsburgh shareholders’ equity

 

 

64,642

 

 

 

58,883

 

Noncontrolling interest

 

 

13,028

 

 

 

12,208

 

Total shareholders’ equity

 

 

77,670

 

 

 

71,091

 

Total liabilities and shareholders’ equity

 

$

536,193

 

 

$

530,896

 

 

See Notes to Condensed Consolidated Financial Statements.

3


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

(in thousands, except per share amounts)

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Net sales:

 

 

 

 

 

 

Net sales

 

$

99,226

 

 

$

110,025

 

Net sales to related parties

 

 

5,039

 

 

 

190

 

Total net sales

 

 

104,265

 

 

 

110,215

 

Operating costs and expenses:

 

 

 

 

 

 

Costs of products sold (excluding depreciation and amortization)

 

 

82,104

 

 

 

92,490

 

Selling and administrative

 

 

13,659

 

 

 

12,973

 

Depreciation and amortization

 

 

4,636

 

 

 

4,670

 

Loss on disposal of assets

 

 

16

 

 

 

 

Total operating costs and expenses

 

 

100,415

 

 

 

110,133

 

Income from operations

 

 

3,850

 

 

 

82

 

Other expense – net:

 

 

 

 

 

 

Interest expense

 

 

(2,726

)

 

 

(2,757

)

Other income – net

 

 

826

 

 

 

923

 

Total other expense – net

 

 

(1,900

)

 

 

(1,834

)

Income (loss) before income taxes

 

 

1,950

 

 

 

(1,752

)

Income tax provision

 

 

(59

)

 

 

(454

)

Net income (loss)

 

 

1,891

 

 

 

(2,206

)

Less: Net income attributable to noncontrolling interest

 

 

749

 

 

 

511

 

Net income (loss) attributable to Ampco-Pittsburgh

 

$

1,142

 

 

$

(2,717

)

 

 

 

 

 

 

 

Net income (loss) per share attributable to Ampco-
   Pittsburgh common shareholders:

 

 

 

 

 

 

Basic

 

$

0.06

 

 

$

(0.14

)

Diluted

 

$

0.06

 

 

$

(0.14

)

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding:

 

 

 

 

 

 

Basic

 

 

19,980

 

 

 

19,729

 

Diluted

 

 

20,167

 

 

 

19,729

 

See Notes to Condensed Consolidated Financial Statements.

4


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(in thousands)

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Net income (loss)

 

$

1,891

 

 

$

(2,206

)

Other comprehensive income (loss), net of income tax where applicable:

 

 

 

 

 

 

Adjustments for changes in:

 

 

 

 

 

 

Foreign currency translation

 

 

4,125

 

 

 

(2,445

)

Unrecognized employee benefit costs (including effects of foreign currency translation)

 

 

(399

)

 

 

93

 

Fair value of cash flow hedges

 

 

780

 

 

 

52

 

Reclassification adjustments for items included in net income (loss):

 

 

 

 

 

 

Amortization of unrecognized employee benefit costs

 

 

(65

)

 

 

(183

)

Settlement of cash flow hedges

 

 

(59

)

 

 

11

 

Other comprehensive income (loss)

 

 

4,382

 

 

 

(2,472

)

Comprehensive income (loss)

 

 

6,273

 

 

 

(4,678

)

Less: Comprehensive income attributable to noncontrolling interest

 

 

820

 

 

 

307

 

Comprehensive income (loss) attributable to Ampco-Pittsburgh

 

$

5,453

 

 

$

(4,985

)

See Notes to Condensed Consolidated Financial Statements.

5


 

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(UNAUDITED)

(in thousands)

 

 

 

Common
Stock

 

 

Additional
Paid-in
Capital

 

 

Retained
Deficit

 

 

Accumulated
Other
Comprehensive
Loss

 

 

Noncontrolling
Interest

 

 

Total

 

Three Months Ended March 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2025

 

$

19,980

 

 

$

178,298

 

 

$

(72,559

)

 

$

(66,836

)

 

$

12,208

 

 

$

71,091

 

Stock-based compensation

 

 

 

 

 

306

 

 

 

 

 

 

 

 

 

 

 

 

306

 

Comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

1,142

 

 

 

 

 

 

749

 

 

 

1,891

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

4,311

 

 

 

71

 

 

 

4,382

 

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

820

 

 

 

6,273

 

Balance at March 31, 2025

 

$

19,980

 

 

$

178,604

 

 

$

(71,417

)

 

$

(62,525

)

 

$

13,028

 

 

$

77,670

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2024

 

$

19,729

 

 

$

177,196

 

 

$

(72,997

)

 

$

(62,989

)

 

$

10,632

 

 

$

71,571

 

Stock-based compensation

 

 

 

 

 

346

 

 

 

 

 

 

 

 

 

 

 

 

346

 

Comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

 

 

 

 

 

 

 

(2,717

)

 

 

 

 

 

511

 

 

 

(2,206

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(2,268

)

 

 

(204

)

 

 

(2,472

)

Comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

307

 

 

 

(4,678

)

Balance at March 31, 2024

 

$

19,729

 

 

$

177,542

 

 

$

(75,714

)

 

$

(65,257

)

 

$

10,939

 

 

$

67,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See Notes to Condensed Consolidated Financial Statements.

6


 

S

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(in thousands)

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Net cash flows (used in) provided by operating activities

 

$

(5,280

)

 

$

4,535

 

 

 

 

 

 

 

 

Cash flows used in investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(2,200

)

 

 

(2,837

)

Proceeds from government grants, used for purchase of equipment

 

 

323

 

 

 

 

Purchases of long-term marketable securities

 

 

(2

)

 

 

(12

)

Proceeds from sale of long-term marketable securities

 

 

168

 

 

 

4

 

Net cash flows used in investing activities

 

 

(1,711

)

 

 

(2,845

)

 

 

 

 

 

 

 

Cash flows (used in) provided by financing activities:

 

 

 

 

 

 

Proceeds from revolving credit facility

 

 

4,666

 

 

 

6,621

 

Payments on revolving credit facility

 

 

(5,666

)

 

 

(4,666

)

Payments on sale-leaseback financing arrangements

 

 

(111

)

 

 

(86

)

Proceeds from equipment financing facility

 

 

 

 

 

1,134

 

Payments on equipment financing facility

 

 

(520

)

 

 

(198

)

Repayment of related-party debt

 

 

 

 

 

(664

)

Repayments of debt

 

 

(96

)

 

 

(113

)

Net cash flows (used in) provided by financing activities

 

 

(1,727

)

 

 

2,028

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

420

 

 

 

(175

)

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

 

(8,298

)

 

 

3,543

 

Cash and cash equivalents at beginning of period

 

 

15,427

 

 

 

7,286

 

Cash and cash equivalents at end of period

 

$

7,129

 

 

$

10,829

 

 

 

 

 

 

 

 

Supplemental information:

 

 

 

 

 

 

Income tax payments (net of refunds)

 

$

487

 

 

$

569

 

Interest payments (net of amounts capitalized)

 

$

2,331

 

 

$

2,347

 

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment in accounts payable

 

$

310

 

 

$

333

 

Finance lease right-of-use assets exchanged for lease liabilities

 

$

23

 

 

$

81

 

Operating lease right-of-use assets exchanged for lease liabilities

 

$

633

 

 

$

28

 

 

See Notes to Condensed Consolidated Financial Statements.

7


 

AMPCO-PITTSBURGH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(in thousands, except per share amounts)

Overview of the Business

Ampco-Pittsburgh Corporation (the “Corporation”) manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the Forged and Cast Engineered Products (“FCEP”) segment and the Air and Liquid Processing (“ALP”) segment. This segment presentation is consistent with how the Corporation’s chief operating decision-maker (“CODM”) evaluates financial performance and makes resource allocation and strategic decisions about the business (Note 18).

Note 1 – Unaudited Condensed Consolidated Financial Statements

The unaudited condensed consolidated balance sheet as of March 31, 2025 and the unaudited condensed consolidated statements of operations, comprehensive income (loss), shareholders’ equity, and cash flows for the three months ended March 31, 2025 and 2024, have been prepared by the Corporation. In the opinion of management, all adjustments, consisting of only normal and recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of the operating results expected for the full year.

Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Corporation’s latest Annual Report on Form 10-K.

Recently Issued Accounting Pronouncements

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement - Disaggregation of Income Statement Expenses. The guidance requires tabular disclosure of certain expenses included in costs of products sold and selling and administrative expenses, such as purchases of inventory and employee compensation, and qualitative description of certain other costs. The guidance becomes effective for the Corporation’s annual period beginning January 1, 2027 and interim periods beginning January 1, 2028. The Corporation is currently evaluating the impact this new standard will have on its annual disclosures in its consolidated financial statements for the year ending December 31, 2027 and interim disclosures thereafter. It will not, however, impact the Corporation’s consolidated financial position, results of operations or cash flows.

In December 2023, the FASB issued ASU 2023-09, Income Taxes - Improvements to Income Tax Disclosures. The guidance requires annual disclosure of specific categories of information within the effective tax rate reconciliation, and income taxes paid and income tax expense disaggregated by jurisdiction. The guidance becomes effective for the Corporation’s annual period beginning January 1, 2025. The Corporation is currently evaluating the impact this new standard will have on its annual disclosures. It will not, however, impact the Corporation’s consolidated financial position, results of operations or cash flows.

Note 2 – Inventories

At March 31, 2025 and December 31, 2024, substantially all inventories were valued using the first-in, first-out method. Inventories were comprised of the following:

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Raw materials

 

$

45,348

 

 

$

46,395

 

Work-in-process

 

 

53,847

 

 

 

49,317

 

Finished goods

 

 

17,096

 

 

 

13,488

 

Supplies

 

 

7,892

 

 

 

7,561

 

Inventories

 

$

124,183

 

 

$

116,761

 

 

8


 

 

Note 3 – Contract Assets

Changes in contract assets were comprised of the following:

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Balance at beginning of the period

$

8,486

 

 

$

4,452

 

Satisfaction of existing contracts

 

(16,323

)

 

 

(9,160

)

Additional revenue earned on new and existing contracts

 

13,236

 

 

 

10,269

 

Other, primarily changes in foreign currency exchange rates

 

90

 

 

 

(51

)

Balance at end of the period

$

5,489

 

 

$

5,510

 

 

Note 4 – Property, Plant and Equipment

Property, plant and equipment were comprised of the following:

 

 

March 31,
2025

 

 

December 31,
2024

 

Land and land improvements

 

$

9,054

 

 

$

8,788

 

Buildings and leasehold improvements

 

 

71,656

 

 

 

70,400

 

Machinery and equipment

 

 

383,577

 

 

 

377,938

 

Construction-in-progress

 

 

4,439

 

 

 

4,544

 

Other

 

 

6,351

 

 

 

6,337

 

 

 

475,077

 

 

 

468,007

 

Accumulated depreciation and amortization

 

 

(327,869

)

 

 

(319,951

)

Property, plant and equipment, net

 

$

147,208

 

 

$

148,056

 

Certain of the above property, plant and equipment are held as collateral including:

The land and building of Union Electric Steel UK Limited (“UES-UK”), an indirect subsidiary of the Corporation, with a book value equal to approximately $2,745 (£2,122) at March 31, 2025, are held as collateral by the trustees of the UES-UK defined benefit pension plan (Note 8).
Certain of the machinery and equipment with a book value equal to approximately $24,239 at March 31, 2025, purchased with proceeds from the equipment finance facility (Note 7), are held as collateral for the equipment financing facility.
Certain land and land improvements and buildings and leasehold improvements with a book value equal to approximately $55,148 are included in the sale-leaseback financing transactions and Disbursement Agreement (Note 7). Title to these assets lies with the lender; however, since the transactions qualified as financing transactions, versus sales, the assets remain recorded on the Corporation’s condensed consolidated balance sheets.
The remaining assets, other than real property, are pledged as collateral for the Corporation’s revolving credit facility (Note 7).

The gross value of assets under finance leases and the related accumulated depreciation approximated $3,058 and $1,590, respectively, as of March 31, 2025 and $2,964 and $1,498, respectively, at December 31, 2024. Depreciation expense approximated $4,550 and $4,582, including depreciation of assets under finance leases of approximately $77 and $82, for the three months ended March 31, 2025 and 2024, respectively.

9


 

Note 5 – Intangible Assets

Intangible assets were comprised of the following:

 

 

March 31,
2025

 

 

December 31,
2024

 

Customer relationships

 

$

5,433

 

 

$

5,158

 

Developed technology

 

 

3,900

 

 

 

3,699

 

Trade name

 

 

2,215

 

 

 

2,054

 

 

 

11,548

 

 

 

10,911

 

Accumulated amortization

 

 

(7,054

)

 

 

(6,656

)

Intangible assets, net

 

$

4,494

 

 

$

4,255

 

Changes in intangible assets consisted of the following:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Balance at beginning of the period

$

4,255

 

 

$

4,947

 

Amortization of intangible assets

 

(86

)

 

 

(88

)

Other, primarily impact from changes in foreign currency exchange rates

 

325

 

 

 

(207

)

Balance at end of the period

$

4,494

 

 

$

4,652

 

 

Note 6 – Customer Related Liabilities

Customer-related liabilities as of March 31, 2025 and December 31, 2024 primarily include liabilities for product warranty claims and deposits received on future orders. The Corporation provides a limited warranty on its products, known as an “assurance-type” warranty, and may issue credit notes or replace products free of charge for valid claims. A warranty is considered an assurance-type warranty if it provides the customer with assurance that the product will function as intended. Historically, warranty claims have been insignificant. The Corporation records a provision for estimated product warranties at the time the underlying sale is recorded. The provision is based on historical experience as a percentage of sales adjusted for probable and known claims.

Changes in the liability for product warranty claims consisted of the following:

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Balance at beginning of the period

$

5,423

 

 

$

5,539

 

Satisfaction of warranty claims

 

(855

)

 

 

(394

)

Provision for warranty claims, net

 

237

 

 

 

588

 

Other, primarily impact from changes in foreign currency exchange rates

 

253

 

 

 

(136

)

Balance at end of the period

$

5,058

 

 

$

5,597

 

Customer deposits represent amounts collected from, or invoiced to, a customer in advance of revenue recognition when necessary to secure the right to a specific product. The liability for customer deposits is reversed when the Corporation satisfies its performance obligations and control of the inventory transfers to the customer, typically when title transfers. The majority of performance obligations related to customer deposits are expected to be satisfied in less than one year. Performance obligations related to customer deposits expected to be satisfied beyond one year have been classified as a noncurrent liability on the condensed consolidated balance sheets.

Changes in customer deposits consisted of the following:

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Balance at beginning of the period

$

21,503

 

 

$

13,078

 

Satisfaction of performance obligations

 

(9,836

)

 

 

(2,567

)

Receipt of additional deposits

 

11,369

 

 

 

7,704

 

Other, primarily impact from changes in foreign currency exchange rates

 

49

 

 

 

(17

)

Balance at end of the period

 

23,085

 

 

 

18,198

 

Deposits - Other noncurrent liabilities

 

(2,746

)

 

 

(4,430

)

Deposits - Other current liabilities

$

20,339

 

 

$

13,768

 

 

10


 

 

Note 7 – Debt

Borrowings were comprised of the following:

 

 

March 31,
2025

 

 

December 31,
2024

 

Revolving credit facility

 

$

55,000

 

 

$

56,000

 

Sale-leaseback financing obligations

 

 

45,674

 

 

 

45,451

 

Equipment financing facility

 

 

16,262

 

 

 

16,782

 

Industrial Revenue Bonds

 

 

9,191

 

 

 

9,191

 

Finance lease liabilities

 

 

1,131

 

 

 

1,156

 

Outstanding borrowings

 

 

127,258

 

 

 

128,580

 

Debt – current portion

 

 

(12,210

)

 

 

(12,186

)

Long-term debt

 

$

115,048

 

 

$

116,394

 

The current portion of debt includes primarily the Industrial Revenue Bonds (“IRBs”). Although the IRBs begin to become due in late 2027, the bonds can be put back to the Corporation on short notice if they are not able to be remarketed; accordingly, the IRBs are classified as a current liability, although the Corporation considers the likelihood of the bonds being put back to the Corporation to be remote.

Revolving Credit Facility

The Corporation is a party to a revolving credit and security agreement with a syndicate of banks that was amended on June 29, 2021 (the “First Amended and Restated Security Agreement”), and subsequently amended on December 17, 2021 and May 26, 2022. The First Amended and Restated Security Agreement provides for a senior secured asset-based revolving credit facility of $100,000, that can be increased to $130,000 at the option of the Corporation and with the approval of the lenders. The revolving credit facility includes sub-limits for letters of credit not to exceed $40,000 and European borrowings not to exceed $30,000, of which up to $7,500 may be allocated for Swedish borrowings. The maturity date for the revolving credit facility is June 29, 2026 and, subject to other terms and conditions of the agreement, would become due on that date.

Availability under the revolving credit facility is based on eligible accounts receivable, inventory and fixed assets. Domestic borrowings from the revolving credit facility bear interest, at the Corporation’s option, at either (i) Secured Overnight Financing Rate (“SOFR”), as adjusted, plus an applicable margin ranging between 2.00% to 2.50% based on the quarterly average excess availability or (ii) the alternate base rate plus an applicable margin ranging between 1.00% to 1.50% based on the quarterly average excess availability. European borrowings denominated in euros, pound sterling or krona bear interest at the Successor Rate as defined in the First Amended and Restated Security Agreement, as amended. As of March 31, 2025 and December 31, 2024, there were no European borrowings outstanding. Additionally, the Corporation is required to pay a commitment fee of 0.25% based on the daily unused portion of the revolving credit facility.

As of March 31, 2025, the Corporation had outstanding borrowings under the revolving credit facility of $55,000. The average interest rate approximated 7.03% and 8.22% for the three months ended March 31, 2025 and 2024, respectively. The Corporation also utilizes a portion of the revolving credit facility for letters of credit (Note 9). As of March 31, 2025, remaining availability under the revolving credit facility approximated $28,586, net of standard availability reserves.

Borrowings outstanding under the revolving credit facility are collateralized by a first priority perfected security interest in substantially all assets of the Corporation and its subsidiaries (other than real property). Additionally, the revolving credit facility contains customary affirmative and negative covenants and limitations including, but not limited to, investments in certain of its subsidiaries, payment of dividends, incurrence of additional indebtedness and guaranties, and acquisitions and divestitures. In addition, the Corporation must maintain a certain level of excess availability or otherwise maintain a minimum fixed charge coverage ratio of not less than 1.05 to 1.00. The Corporation was in compliance with the applicable bank covenants as of March 31, 2025.

Sale-Leaseback Financing Obligations

In September 2018, Union Electric Steel Corporation (“UES”), an indirect subsidiary of the Corporation, completed a sale-leaseback financing transaction with Store Capital Acquisitions, LLC (“STORE”) for certain of its real property, including its manufacturing facilities in Valparaiso, Indiana and Burgettstown, Pennsylvania, and its manufacturing facility and corporate headquarters located in Carnegie, Pennsylvania (the “UES Properties”).

In August 2022, Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation, completed a sale-leaseback financing transaction with STORE for certain of its real property, including its manufacturing facilities in Lynchburg, Virginia and Amherst, Virginia.

11


 

In October 2022, Air & Liquid completed a sale-leaseback financing transaction with STORE for its real property, including its manufacturing facility, located in North Tonawanda, New York (collectively with the Virginia properties, the “ALP Properties”).

In connection with the August 2022 sale-leaseback financing transaction, and as modified by the October 2022 sale-leaseback financing transaction, UES and STORE entered into a Second Amended and Restated Master Lease Agreement (the “Restated Lease”), which amended and restated the existing lease agreement between UES and STORE.

Pursuant to the Restated Lease, UES will lease the ALP Properties and the UES Properties (collectively, the “Properties”), subject to the terms and conditions of the Restated Lease, and UES will sublease the ALP Properties to Air & Liquid on the same terms as the Restated Lease. The Restated Lease provides for an initial term of 20 years; however, UES may extend the lease for the Properties for four successive periods of five years each. If fully extended, the Restated Lease would expire in August 2062. UES also has the option to repurchase the Properties, which it may, and intends to, exercise in 2032, for a price equal to the greater of (i) the Fair Market Value of the Properties or (ii) 115% of Lessor’s Total Investment, with such terms defined in the Restated Lease.

In August 2022, in connection with the Restated Lease, UES and STORE entered into a Disbursement Agreement pursuant to which STORE agreed to provide up to $2,500 to UES towards certain leasehold improvements in the Carnegie, Pennsylvania manufacturing facility. In June 2023, UES received $2,500 of proceeds from the Disbursement Agreement. The annual payments for the Properties (the “Base Annual Rent”) have been adjusted to repay the $2,500 over the balance of the initial term of the Restated Lease of 20 years. Advances under the Disbursement Agreement are secured by a first priority security interest in the leasehold improvements.

At March 31, 2025, the Base Annual Rent, including the Disbursement Agreement, is equal to $3,719, payable in equal monthly installments. Each October through 2052, the Base Annual Rent will increase by an amount equal to the lesser of 2.04% or 1.25 times the change in the consumer price index, as defined in the Restated Lease. The Base Annual Rent during the remaining ten years of the Restated Lease will equal the Fair Market Rent, as defined in the Restated Lease.

The Restated Lease and the Disbursement Agreement contain certain representations, warranties, covenants, obligations, conditions, indemnification provisions, and termination provisions customary for those types of agreements. The Corporation was in compliance with the applicable covenants as of March 31, 2025.

The effective interest rate approximated 8.26% and 8.24% for the three months ended March 31, 2025 and 2024, respectively.

Equipment Financing Facility

In September 2022, UES and Clarus Capital Funding I, LLC (“Clarus”) entered into a Master Loan and Security Agreement, pursuant to which UES could borrow up to $20,000 to finance certain equipment purchases associated with a capital program at certain of the Corporation’s FCEP locations. Each borrowing constitutes a secured loan transaction (each, a “Term Note”). Each Term Note has a term of 84 months in arrears fully amortizing, commencing on the date of the Term Note, and is secured by a first priority security interest in and to all of UES’ rights, title and interests in the underlying equipment.

Interest on each Term Note accrues at an annual fixed rate ranging between 8.40% and 9.22%. The effective interest rates approximated 8.65% and 8.99% for the three months ended March 31, 2025 and 2024, respectively. As of March 31, 2025, monthly payments of principal and interest approximate $293 and continue through mid-2031.

Industrial Revenue Bonds (“IRBs”)

The Corporation has two IRBs outstanding: (i) $7,116 taxable IRB maturing in 2027, interest at a floating rate which averaged 4.43% and 5.36% for the three months ended March 31, 2025 and 2024, respectively, and (ii) $2,075 tax-exempt IRB maturing in 2029, interest at a floating rate which averaged 2.97% and 3.70% for the three months ended March 31, 2025 and 2024, respectively. The IRBs are secured by letters of credit of equivalent amounts and are remarketed periodically at which time the interest rates are reset. If the IRBs are not able to be remarketed, although considered a remote possibility by the Corporation, the bondholders can seek reimbursement immediately from the letters of credit; accordingly, the IRBs are recorded as current debt on the condensed consolidated balance sheets.

12


 

Note 8 – Pension and Other Postretirement Benefits

Contributions to the Corporation’s employee benefit plans were as follows:

 

 

Three Months Ended March 31,

 

 

 

2025

 

2024

 

U.S. defined benefit pension plans

 

$

796

 

$

 

U.S. defined benefit nonqualified pension plans (e.g. payments)

 

$

192

 

$

192

 

Foreign defined benefit pension plans

 

$

106

 

$

120

 

Other postretirement benefits (e.g., net payments)

 

$

85

 

$

88

 

U.K. defined contribution pension plan

 

$

70

 

$

66

 

U.S. defined contribution plan

 

$

854

 

$

929

 

Net periodic pension and other postretirement benefit costs included the following components:

 

 

Three Months Ended March 31,

 

U.S. Defined Benefit Pension Plans (a)

 

2025

 

 

2024

 

Service cost

 

$

7

 

 

$

10

 

Interest cost

 

 

2,249

 

 

 

2,329

 

Expected return on plan assets

 

 

(2,871

)

 

 

(3,401

)

Amortization of actuarial loss

 

 

142

 

 

 

45

 

Net benefit income

 

$

(473

)

 

$

(1,017

)

a) Includes the nonqualified defined benefit pension plan.

 

 

Three Months Ended March 31,

 

Foreign Defined Benefit Pension Plans

 

2025

 

 

2024

 

Service cost

 

$

26

 

 

$

31

 

Interest cost

 

 

457

 

 

 

456

 

Expected return on plan assets

 

 

(525

)

 

 

(478

)

Amortization of prior service credit

 

 

(70

)

 

 

(71

)

Amortization of actuarial loss

 

 

197

 

 

 

180

 

Net benefit expense

 

$

85

 

 

$

118

 

 

 

 

Three Months Ended March 31,

 

Other Postretirement Benefit Plans

 

2025

 

 

2024

 

Service cost

 

$

42

 

 

$

43

 

Interest cost

 

 

90

 

 

 

98

 

Amortization of prior service credit

 

 

(256

)

 

 

(256

)

Amortization of actuarial gain

 

 

(78

)

 

 

(81

)

Net benefit income

 

$

(202

)

 

$

(196

)

 

Note 9 – Commitments and Contingent Liabilities

Outstanding standby and commercial letters of credit and bank guarantees as of March 31, 2025 equaled $15,344, of which approximately one-half serves as collateral for the IRB debt. Outstanding surety bonds as of March 31, 2025 approximated $3,384 (SEK 33,900), which guarantee certain obligations under a credit insurance arrangement for certain of the Corporation’s foreign pension commitments.

At March 31, 2025, commitments for future capital expenditures approximated $5,200.

See Note 12 for derivative instruments, Note 15 for litigation and Note 16 for environmental matters.

Note 10 – Equity Rights Offering

13


 

In September 2020, the Corporation completed an equity rights offering, issuing 5,507,889 shares of its common stock and 12,339,256 Series A warrants to existing shareholders. The shares of common stock and warrants are classified as equity instruments in the condensed consolidated statements of shareholders’ equity. Each Series A warrant provides the holder with the right to purchase 0.4464 shares of common stock at an exercise price of $2.5668, or $5.75 per whole share of common stock, and expires on August 1, 2025. Series A warrants outstanding totaled 10,941,770 and 10,941,869 at March 31, 2025 and December 31, 2024, respectively.

Note 11 – Accumulated Other Comprehensive Loss

Net change and ending balances for the various components of accumulated other comprehensive loss as of and for the three months ended March 31, 2025 and 2024 are summarized below. All amounts are net of tax where applicable.

 

 

Foreign
Currency
Translation

 

 

Unrecognized
Employee
Benefit Costs

 

 

Cash Flow
Hedges

 

 

Total
Accumulated Other
Comprehensive Loss

 

 

Less:
Noncontrolling
Interest

 

 

Accumulated Other
Comprehensive Loss
Attributable to Ampco-Pittsburgh

 

Balance at January 1, 2025

 

$

(27,691

)

 

$

(39,856

)

 

$

(102

)

 

$

(67,649

)

 

$

(813

)

 

$

(66,836

)

Net change

 

 

4,125

 

 

 

(464

)

 

 

721

 

 

 

4,382

 

 

 

71

 

 

 

4,311

 

Balance at March 31, 2025

 

$

(23,566

)

 

$

(40,320

)

 

$

619

 

 

$

(63,267

)

 

$

(742

)

 

$

(62,525

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2024

 

$

(23,161

)

 

$

(40,490

)

 

$

186

 

 

$

(63,465

)

 

$

(476

)

 

$

(62,989

)

Net change

 

 

(2,445

)

 

 

(90

)

 

 

63

 

 

 

(2,472

)

 

 

(204

)

 

 

(2,268

)

Balance at March 31, 2024

 

$

(25,606

)

 

$

(40,580

)

 

$

249

 

 

$

(65,937

)

 

$

(680

)

 

$

(65,257

)

 

The following summarizes the line items affected on the condensed consolidated statements of operations for components reclassified from accumulated other comprehensive loss. Amounts in parentheses represent credits to net income (loss).

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Amortization of unrecognized employee benefit costs:

 

 

 

 

 

Other loss – net

$

(65

)

 

$

(183

)

Income tax effect

 

 

 

 

 

Net of tax

$

(65

)

 

$

(183

)

Settlements of cash flow hedges:

 

 

 

 

 

Depreciation and amortization (foreign currency purchase contracts)

$

(6

)

 

$

(6

)

Costs of products sold (excluding depreciation and
amortization) (futures contracts – copper and aluminum)

 

(55

)

 

 

18

 

Total before income tax

 

(61

)

 

 

12

 

Income tax effect

 

2

 

 

 

(1

)

Net of tax

$

(59

)

 

$

11

 

The income tax effect associated with the various components of other comprehensive income (loss) for the three months ended March 31, 2025 and 2024 is summarized below. Amounts in parentheses represent credits to net income (loss) when reclassified to earnings. Certain amounts have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized. Foreign currency translation adjustments exclude the effect of income taxes since earnings of non-U.S. subsidiaries are deemed to be reinvested for an indefinite period of time.

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Income tax effect associated with changes in:

 

 

 

 

 

 

Unrecognized employee benefit costs

 

$

 

 

$

 

Fair value of cash flow hedges

 

$

21

 

 

$

2

 

Income tax effect associated with reclassification adjustments:

 

 

 

 

 

 

Amortization of unrecognized employee benefit costs

 

$

 

 

$

 

Settlement of cash flow hedges

 

$

2

 

 

$

(1

)

 

14


 

Note 12 – Derivative Instruments

Certain divisions of the ALP segment are subject to risk from increases in the price of commodities (aluminum and copper) used in the production of inventory. To minimize this risk, futures contracts are entered into which are designated as cash flow hedges. In March 2025, given the dramatic escalation in the price of copper futures and sufficient supply of copper through approximately mid-2025, the Corporation terminated its existing futures contracts for copper resulting in a pre-tax termination gain of approximately $559. The termination gain will be reclassified to earnings when the projected sales occur. Approximately $537 of the termination gain is expected to be released to earnings in 2025 with the balance expected to be released in the first quarter of 2026. At March 31, 2025, approximately 50%, or $394, of anticipated aluminum purchases over the next four months are hedged. At March 31, 2024, approximately 52%, or $2,787, of anticipated copper purchases over the next nine months and 56%, or $566, of anticipated aluminum purchases over the next six months were hedged.

The Corporation periodically enters into purchase commitments to cover a portion of its anticipated natural gas and electricity usage. The commitments qualify as normal purchases and, accordingly, are not reflected on the condensed consolidated balance sheets. At March 31, 2025, the Corporation has purchase commitments covering approximately 26%, or $1,198, of anticipated natural gas usage through December 31, 2025 for two of its subsidiaries and approximately 32%, or $945, of anticipated electricity usage through December 31, 2025 for two of its subsidiaries. At March 31, 2024, the Corporation had purchase commitments covering approximately 6%, or $2,365, of anticipated natural gas usage through December 31, 2025 for two of its subsidiaries and approximately 12%, or $1,440, of anticipated electricity usage through December 31, 2025 for two of its subsidiaries. Purchases of natural gas and electricity under previously existing commitments equaled $1,124 and $979 for the three months ended March 31, 2025 and 2024, respectively.

The Corporation previously entered into foreign currency purchase contracts to manage the volatility associated with euro-denominated progress payments to be made for certain machinery and equipment. Upon occurrence of an anticipated purchase and placement of the underlying fixed asset in service, the foreign currency purchase contract was settled and the change in fair value of the foreign currency purchase contract was deferred in accumulated other comprehensive loss and is being reclassified to earnings (depreciation and amortization expense) over the life of the underlying asset (approximately 15 years, through 2026).

No portion of the existing cash flow hedges is considered to be ineffective, including any ineffectiveness arising from the unlikelihood of an anticipated transaction to occur. Additionally, no amounts have been excluded from assessing the effectiveness of a hedge. The Corporation does not enter into derivative transactions for speculative purposes and, therefore, holds no derivative instruments for trading purposes.

Gain (loss) on foreign exchange transactions included in other expense – net equaled $221 for the three months ended March 31, 2025, and $(492) for the three months ended March 31, 2024.

The change in the fair value of the cash flow contracts is recorded as a component of accumulated other comprehensive loss. The balances as of March 31, 2025 and 2024 and the amounts recognized as and reclassified from accumulated other comprehensive loss for each of the periods are summarized below. Amounts are after tax where applicable. Certain amounts recognized as comprehensive income (loss) or reclassified from accumulated other comprehensive loss have no tax effect due to the Corporation having a valuation allowance recorded against the deferred income tax assets for the jurisdiction where the income or expense is recognized.

 

 

Beginning of
the Period

 

 

Recognized

 

 

Reclassified

 

 

End of
the Period

 

'Three Months Ended March 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency purchase contracts

 

$

54

 

 

$

 

 

$

6

 

 

$

48

 

Futures contracts – copper and aluminum

 

 

(156

)

 

 

780

 

 

 

53

 

 

 

571

 

 

$

(102

)

 

$

780

 

 

$

59

 

 

$

619

 

Three Months Ended March 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency purchase contracts

 

$

81

 

 

$

 

 

$

6

 

 

$

75

 

Futures contracts – copper and aluminum

 

 

105

 

 

 

52

 

 

 

(17

)

 

 

174

 

 

$

186

 

 

$

52

 

 

$

(11

)

 

$

249

 

 

15


 

The change in fair value reclassified or expected to be reclassified from accumulated other comprehensive loss to earnings is summarized below. All amounts are pre-tax.

 

 

Location of Gain (Loss)
in Statements

 

Estimated to
be Reclassified
in the Next 12 Months

 

 

Three Months Ended March 31,

 

 

 

of Operations

 

 

 

 

2025

 

 

2024

 

Foreign currency purchase contracts

 

Depreciation and amortization

 

$

27

 

 

$

6

 

 

$

6

 

Futures contracts – copper and aluminum

 

Costs of products sold
(excluding depreciation and amortization)

 

$

587

 

 

$

55

 

 

$

(18

)

 

Note 13 – Fair Value

The Corporation’s financial assets and liabilities reported at fair value in the condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024 were as follows:

 

 

Quoted Prices
in Active
Markets for
Identical Inputs
(Level 1)

 

 

Significant
Other
Observable
Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

 

Total

 

As of March 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent assets

 

$

2,812

 

 

$

 

 

$

 

 

$

2,812

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2024

 

 

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

 

 

 

 

Other noncurrent assets

 

$

3,026

 

 

$

 

 

$

 

 

$

3,026

 

The investments held as other noncurrent assets represent assets held in the “Rabbi” trust for the purpose of providing benefits under the non-qualified defined benefit pension plan. The fair value of the investments is based on quoted prices of the investments in active markets. The fair value of futures contracts is based on market quotations. The fair values of the variable-rate IRB debt and borrowings under the revolving credit facility and other debt facilities approximate their carrying values. Additionally, the fair values of trade receivables and trade payables approximate their carrying values.

Note 14 – Stock-Based Compensation

At March 31, 2025, the Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan, as amended (the “Incentive Plan”), authorizes the issuance of up to 3,700,000 shares of the Corporation’s common stock for awards under the Incentive Plan. On May 8, 2025, at the Corporation's Annual Meeting of Shareholders, the shareholders approved an increase in the number of shares authorized under the Incentive Plan to 4,200,000 shares, an increase of 500,000 shares. Awards under the Incentive Plan may include incentive stock options and non-qualified stock options, stock appreciation rights, restricted shares and restricted stock units, performance awards, other stock-based awards, or short-term cash incentive awards. If any award is canceled, terminates, expires, or lapses for any reason prior to the issuance of the shares, or if the shares are issued under the Incentive Plan and thereafter are forfeited to the Corporation, the shares subject to such awards and the forfeited shares will not count against the aggregate number of shares available under the Incentive Plan. Shares tendered or withheld to pay the option exercise price or tax withholding will continue to count against the aggregate number of shares of common stock available for grant under the Incentive Plan. Any shares repurchased by the Corporation with cash proceeds from the exercise of options will not be added back to the pool of shares available for grant under the Incentive Plan.

The Incentive Plan may be administered by the Board of Directors or the Compensation Committee of the Board of Directors. The Compensation Committee has the authority to determine, within the limits of the express provisions of the Incentive Plan, the individuals to whom the awards will be granted and the nature, amount and terms of such awards.

The Incentive Plan also provides for equity-based awards during any one year to non-employee members of the Board of Directors, based on the grant date fair value, not to exceed $200. The limit does not apply to shares received by a non-employee director at his or her election in lieu of the director’s retainer for board service. The restricted stock awards vest on the one-year anniversary of the grant date.

16


 

Stock-based compensation expense, including expense associated with equity-based awards granted to non-employee members of the Board of Directors, for the three months ended March 31, 2025 and 2024 equaled $306 and $346, respectively. The income tax benefit recognized in the condensed consolidated statements of operations was not significant due to the Corporation having a valuation allowance recorded against its deferred income tax assets for the majority of the jurisdictions where the expense was recognized.

Note 15 – Litigation

The Corporation and its subsidiaries are involved in various claims and lawsuits incidental to their businesses from time to time and are also subject to asbestos litigation.

Asbestos Litigation

Claims have been asserted alleging personal injury from exposure to asbestos-containing components historically used in some products manufactured by predecessors of Air & Liquid (the “Asbestos Liability”). Air & Liquid, and in some cases the Corporation, are defendants (among a number of defendants, often in excess of 50 defendants) in claims filed in various state and federal courts.

Asbestos Claims

The following table reflects approximate information about the number of claims for Asbestos Liability against Air & Liquid and the Corporation for the three months ended March 31, 2025 and 2024 (number of claims not in thousands). The majority of the settlement and defense costs were reported and paid by insurance carriers. Because claims are often filed and can be settled or dismissed in large groups, the amount and timing of settlements, as well as the number of open claims, can fluctuate significantly from period to period.

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Total claims pending at the beginning of the period

 

 

6,363

 

 

 

6,310

 

New claims served

 

 

321

 

 

 

324

 

Claims dismissed

 

 

(108

)

 

 

(222

)

Claims settled

 

 

(171

)

 

 

(116

)

Total claims pending at the end of period (1)

 

 

6,405

 

 

 

6,296

 

Administrative closures (2)

 

 

(3,320

)

 

 

(3,228

)

Total active claims at the end of the period

 

 

3,085

 

 

 

3,068

 

Gross settlement and defense costs paid in period (in 000’s)

 

$

6,775

 

 

$

6,907

 

Average gross settlement and defense costs per claim resolved (in 000’s) (3)

 

$

24.28

 

 

$

20.43

 

(1)
Included as “total claims pending” are approximately 1,637 and 1,641 claims at March 31, 2025 and 2024, respectively, classified in various jurisdictions as “inactive” or transferred to a state or federal judicial panel on multi-district litigation.
(2)
Administrative closures include (i) mesothelioma claims filed five or more years ago; (ii) non-mesothelioma claims filed six or more years ago; (iii) claims previously classified in various jurisdictions as “inactive;” and (iv) claims transferred to a state or federal judicial panel on multi-district litigation.
(3)
Claims resolved do not include claims administratively closed.

Asbestos Insurance

The Corporation and Air & Liquid are parties to a series of settlement agreements (“Settlement Agreements”) with insurance carriers that have coverage obligations for the Asbestos Liability (the “Settling Insurers”). Under the Settlement Agreements, the Settling Insurers accept financial responsibility, subject to the terms and conditions of the respective agreements, including overall coverage limits, for pending and future claims for the Asbestos Liability. The Settlement Agreements encompass the majority of insurance policies that provide coverage for claims for the Asbestos Liability.

The Settlement Agreements acknowledge Howden North America, Inc. (“Howden”) is entitled to coverage under policies covering the Asbestos Liability for claims arising out of the historical products manufactured or distributed by Buffalo Forge, a former subsidiary of the Corporation (the “Products”), which was acquired by Howden. The Settlement Agreements do not provide for any prioritization on access to the applicable policies or any sub-limits of liability as to Howden or the Corporation and Air & Liquid and, accordingly, Howden may access the coverage afforded by the Settling Insurers for any covered claim arising out of the Products. In general, access by Howden to the coverage afforded by the Settling Insurers for the Products will erode coverage under the Settlement Agreements available to the Corporation and Air & Liquid for the Asbestos Liability.

Asbestos Valuations

The Corporation, with the assistance of a nationally recognized expert in the valuation of asbestos liabilities, reviews the Asbestos Liability and the underlying assumptions on a regular basis to determine whether any adjustment to the Asbestos Liability or the underlying assumptions are necessary.

17


 

When warranted, the Asbestos Liability is adjusted to consider current trends and new information that becomes available. In conjunction with the regular updates of the estimated Asbestos Liability, the Corporation also develops an estimate of defense costs expected to be incurred with settling the Asbestos Liability and probable insurance recoveries for the Asbestos Liability and defense costs.

In developing the estimate of probable defense costs, the Corporation considers several factors including, but not limited to, current and historical defense-to-indemnity cost ratios and expected defense-to-indemnity cost ratios. In developing the estimate of probable insurance recoveries, the Corporation considers the expert’s projection of settlement costs for the Asbestos Liability and management’s projection of associated defense costs. In addition, the Corporation consults with its outside legal counsel on insurance matters and a nationally recognized insurance consulting firm it retains to assist with certain policy allocation matters. The Corporation also considers a number of other factors including the Settlement Agreements in effect, policy exclusions, policy limits, policy provisions regarding coverage for defense costs, attachment points, gaps in the coverage, policy exhaustion, the nature of the underlying claims for the Asbestos Liability, estimated erosion of insurance limits on account of claims against Howden arising out of the Products, prior impairment of policies, insolvencies among certain of the insurance carriers, and creditworthiness of the remaining insurance carriers based on publicly available information. Based on these factors, the Corporation estimates the probable insurance recoveries for the Asbestos Liability and defense costs for the corresponding time frame of the Asbestos Liability.

The following table summarizes activity relating to Asbestos Liability for the three months ended March 31, 2025 and 2024.

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Asbestos liability, beginning of the year

 

$

207,092

 

 

$

238,679

 

Settlement and defense costs paid

 

 

(6,775

)

 

 

(6,907

)

Asbestos liability, end of the period

 

$

200,317

 

 

$

231,772

 

The following table summarizes activity relating to insurance recoveries for the three months ended March 31, 2025 and 2024.

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Insurance receivable – asbestos, beginning of the year

 

$

139,295

 

 

$

160,245

 

Settlement and defense costs paid by insurance carriers

 

 

(4,408

)

 

 

(3,285

)

Insurance receivable – asbestos, end of the period

 

$

134,887

 

 

$

156,960

 

The insurance receivable does not assume any recovery from insolvent carriers. A substantial majority of the insurance recoveries deemed probable is from insurance companies rated A – (excellent) or better by A.M. Best Corporation. There can be no assurance, however, there will not be insolvencies among the relevant insurance carriers, or the assumed percentage recoveries for certain carriers will prove correct.

Asbestos Assumptions

The amounts recorded for the Asbestos Liability and insurance receivable rely on assumptions based on currently known facts and strategy. The Corporation’s actual expenses or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the Corporation’s or the experts’ calculations vary significantly from actual results. Key variables in these assumptions include the forecast of the population likely to have been exposed to asbestos; the number of people likely to develop an asbestos-related disease; the estimated number of people likely to file an asbestos-related injury claim against the Corporation or its subsidiaries; an analysis of pending cases, by type of injury claimed and jurisdiction where the claim is filed; average settlement value of claims, by type of injury claimed and jurisdiction of filing; the number and nature of new claims to be filed each year; the average cost of disposing of each new claim; the average annual defense costs; compliance by relevant parties with the terms of the Settlement Agreements; ability to reach acceptable agreements with insurance carriers currently not a party to a Settlement Agreement or at a coverage amount less than anticipated; and the solvency risk with respect to the relevant insurance carriers. Other factors that may affect the Asbestos Liability and ability to recover under the Corporation’s insurance policies include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation.

The Corporation intends to continue to evaluate the Asbestos Liability, related insurance receivable, the sufficiency of its allowance for expected credit losses and the underlying assumptions on a regular basis to determine whether any adjustments to the estimates are required. Due to the uncertainties surrounding asbestos litigation and insurance recovery, these regular reviews may result in the Corporation adjusting its current reserve; however, the Corporation is currently unable to estimate such future adjustments. Adjustments, if any, to the Corporation’s estimate of the Asbestos Liability, insurance receivable and/or allowance for expected credit losses could be material to the operating results for the period in which the adjustments to the liability, receivable or allowance are recorded and to the Corporation’s condensed consolidated financial position, results of operations and liquidity.

18


 

Note 16 – Environmental Matters

The Corporation is currently performing certain remedial actions in connection with the sale of real estate previously owned and periodically incurs costs to maintain compliance with environmental laws and regulations. Environmental exposures are difficult to assess and estimate for numerous reasons, including lack of reliable data, the multiplicity of possible solutions, the years of remedial and monitoring activity required, and identification of new sites. The undiscounted potential liability for remedial actions and environmental compliance measures approximated $100 at March 31, 2025 and December 31, 2024.

Note 17 – Related Parties

Åkers TISCO Roll Co., Ltd. (“ATR”), a 59.88% indirectly owned joint venture of UES, periodically has loans outstanding with its minority shareholder. No borrowings were outstanding as of March 31, 2025 or 2024. Loan activity for the three months ended March 31, 2025 and 2024 was as follows:

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2025

 

 

2024

 

 

2024

 

 

 

USD

 

 

RMB

 

 

USD

 

 

RMB

 

Balance at beginning of the period

 

$

 

 

 

 

 

$

665

 

 

 

4,713

 

Borrowings

 

 

 

 

 

 

 

 

 

 

 

 

Repayments

 

 

 

 

 

 

 

 

(664

)

 

 

(4,713

)

Foreign exchange

 

 

 

 

 

 

 

 

(1

)

 

 

 

Balance at end of the period

 

$

 

 

 

 

 

$

 

 

 

 

Interest on borrowings accrues at the three-to-five-year loan interest rate set by the People’s Bank of China, which approximated 4.35% for the three months ended March 31, 2024. For the three months ended March 31, 2024, ATR paid $2 (RMB 17) of interest. No interest was outstanding as of March 31, 2025 or December 31, 2024.

ATR has sales to and purchases from ATR’s minority shareholder and its affiliates and sales to a shareholder of one of the Corporation’s other joint ventures in China and its affiliates. These sales and purchases, which were in the ordinary course of business, for the three months ended March 31, 2025 and 2024 were as follows:

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2025

 

 

2024

 

 

2024

 

 

 

USD

 

 

RMB

 

 

USD

 

 

RMB

 

Purchases from related parties

 

$

2,076

 

 

 

15,089

 

 

$

1,237

 

 

 

8,848

 

Sales to related parties

 

$

5,039

 

 

 

36,621

 

 

$

190

 

 

 

1,356

 

 

Balances outstanding with ATR’s minority shareholder including its affiliates and the other joint venture’s shareholder and its affiliates as of March 31, 2025 and December 31, 2024 were as follows:

 

 

March 31, 2025

 

 

March 31, 2025

 

 

December 31, 2024

 

 

December 31, 2024

 

 

 

USD

 

 

RMB

 

 

USD

 

 

RMB

 

Accounts receivable from related parties

 

$

2,380

 

 

 

17,272

 

 

$

1,839

 

 

 

13,422

 

Accounts payable to related parties

 

$

623

 

 

 

4,519

 

 

$

411

 

 

 

3,001

 

 

The manufacturing facilities of ATR are located on land leased by ATR from the other partner. The land lease commenced in 2007, the date the joint venture was formed, and continues through 2054, the expected end date of the joint venture, and includes variable lease payment provisions based on the land standard price prevailing in Taiyuan, China, where the joint venture is located. Rent paid by ATR to the other partner approximated $31 (RMB 223) for each of the three months ended March 31, 2025 and 2024, which is included in purchases from related parties.

Note 18 – Business Segments

The FCEP segment produces forged hardened steel rolls, cast rolls and forged engineered products (“FEP”). Forged hardened steel rolls are used primarily in hot and cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot strip mills, medium/heavy section mills, roughing mills, and plate mills. FEP principally are sold to customers in the steel distribution market, oil and gas industry and the aluminum and plastic extrusion industries. The segment has operations in the United States, England, Sweden, and Slovenia and equity interests in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North American and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

19


 

The ALP segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including original equipment manufacturers and commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment utilizes an independent group of sales offices located throughout the United States and Canada.

Net sales by product line for the three months ended March 31, 2025 and 2024 are outlined below.

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Net sales:

 

 

 

 

 

Forged and Cast Engineered Products

 

 

 

 

 

Forged and cast mill rolls

$

68,622

 

 

$

73,396

 

FEP

 

3,665

 

 

 

3,793

 

Forged and Cast Engineered Products

 

72,287

 

 

 

77,189

 

 

 

 

 

 

 

Air and Liquid Processing

 

 

 

 

 

Air handling systems

 

10,628

 

 

 

12,510

 

Heat exchange coils

 

11,525

 

 

 

10,823

 

Centrifugal pumps

 

9,825

 

 

 

9,693

 

Air and Liquid Processing

 

31,978

 

 

 

33,026

 

Total Reportable Segments

$

104,265

 

 

$

110,215

 

The accounting policies for each segment are the same as those described in Item 8, Financial Statements and Supplementary Data, in Part II of our Annual Report on Form 10-K for the year ended December 31, 2024. The Corporation's Chief Executive Officer is the Corporation’s CODM.

The Corporation measures each segment’s profitability based on income from operations. Segment income from operations excludes interest expense, other income and expense items and Corporate costs. Along with other measures, including non-GAAP measures, the CODM uses segment income from operations when assessing segment performance and when making decisions to allocate financial resources between segments, primarily through periodic budgeting and segment performance reviews.

Summarized financial information concerning the Corporation’s reportable segments is shown in the following tables.

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

FCEP

 

 

ALP

 

 

Total

 

 

FCEP

 

 

ALP

 

 

Total

 

Net sales

$

72,287

 

 

$

31,978

 

 

$

104,265

 

 

$

77,189

 

 

$

33,026

 

 

$

110,215

 

Less:(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products sold (excluding depreciation and amortization)

 

57,613

 

 

 

24,491

 

 

 

 

 

 

65,451

 

 

 

27,039

 

 

 

 

Selling and administrative

 

6,385

 

 

 

3,725

 

 

 

 

 

 

5,732

 

 

 

3,765

 

 

 

 

Depreciation and amortization

 

4,368

 

 

 

268

 

 

 

 

 

 

4,430

 

 

 

240

 

 

 

 

Loss on disposal of assets

 

16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment income from operations

$

3,905

 

 

$

3,494

 

 

 

7,399

 

 

$

1,576

 

 

$

1,982

 

 

 

3,558

 

Reconciliation to income (loss) before income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate costs (2)

 

 

 

 

 

 

 

(3,549

)

 

 

 

 

 

 

 

 

(3,476

)

Interest expense

 

 

 

 

 

 

 

(2,726

)

 

 

 

 

 

 

 

 

(2,757

)

Other income - net (3)

 

 

 

 

 

 

 

826

 

 

 

 

 

 

 

 

 

923

 

Income (loss) before income taxes

 

 

 

 

 

 

$

1,950

 

 

 

 

 

 

 

 

$

(1,752

)

(1)
The significant expense categories and amounts align with the segment-level information regularly provided to the CODM.
(2)
Corporate costs represent the operating expenses of the corporate office and other costs not allocated to the segments.
(3)
Other income - net includes net pension and other postretirement income, gains and losses on foreign exchange transactions, unrealized gains and losses on Rabbi trust investments, and investment income.

 

20


 

 

 

Capital Expenditures

Depreciation and
Amortization Expense

Identifiable Assets(1)

 

 

 

March 31,
2025

 

 

March 31,
2024

 

 

March 31,
2025

 

 

March 31,
2024

 

 

March 31,
2025

 

 

December 31,
2024

 

Forged and Cast Engineered Products

 

$

1,399

 

 

$

2,548

 

 

$

4,368

 

 

$

4,430

 

 

$

303,618

 

 

$

289,129

 

Air and Liquid Processing

 

 

801

 

 

 

289

 

 

 

268

 

 

 

240

 

 

 

225,960

 

 

 

230,171

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,615

 

 

 

11,596

 

Consolidated total

 

$

2,200

 

 

$

2,837

 

 

$

4,636

 

 

$

4,670

 

 

$

536,193

 

 

$

530,896

 

 

 

 

Long-lived Assets(2)

 

 

Net Sales by
Geographic Area(3)

 

 

Income (Loss)
Before Income Taxes

 

 

Geographic Areas:

 

March 31,
2025

 

 

December 31,
2024

 

 

March 31,
2025

 

 

March 31,
2024

 

 

March 31,
2025

 

 

March 31,
2024

 

United States

 

$

229,733

 

 

$

235,785

 

 

$

59,896

 

 

$

69,764

 

 

$

397

 

 

$

(2,223

)

 

Foreign

 

 

57,116

 

 

 

55,473

 

 

 

44,369

 

 

 

40,451

 

 

 

1,553

 

 

 

471

 

 

Consolidated total

 

$

286,849

 

 

$

291,258

 

 

$

104,265

 

 

$

110,215

 

 

$

1,950

 

 

$

(1,752

)

 

(1)
Identifiable assets for the FCEP segment include investments in joint ventures of $2,175 at March 31, 2025 and December 31, 2024. Identifiable assets for the ALP segment include asbestos-related insurance receivables of $134,887 and $139,295 at March 31, 2025 and December 31, 2024, respectively. Identifiable assets for Corporate represent primarily cash and cash equivalents and other items not allocated to reportable segments.
(2)
Long-lived assets exclude deferred income tax assets. Long-lived assets in the U.S. include noncurrent asbestos-related insurance receivables of $119,887 and $124,295 at March 31, 2025 and December 31, 2024, respectively. Foreign long-lived assets primarily represent assets of the foreign operations.
(3)
Net sales are attributed to the geographic areas based on the location of the customer. Sales to individual foreign countries were less than 10% of consolidated net sales for each of the periods. The majority of foreign net sales for each of the periods is attributable to the FCEP segment.

 

21


 

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

(in thousands, except per share amounts)

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by us or on behalf of Ampco-Pittsburgh Corporation and its subsidiaries (collectively, “we,” “us,” “our,” or the “Corporation”). Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of this Quarterly Report on Form 10-Q, as well as the condensed consolidated financial statements and notes hereto, may include, but are not limited to, statements about operating performance, trends and events we expect or anticipate will occur in the future, statements about sales and production levels, timing of orders for our products, restructurings, the impact from pandemics and geopolitical conflicts, profitability and anticipated expenses, inflation, the global supply chain, tariffs and global trade, future proceeds from the exercise of outstanding warrants, and cash outflows. All statements in this document other than statements of historical fact are statements that are, or could be, deemed “forward-looking statements” within the meaning of the Act and words such as “may,” “will,” “intend,” “believe,” “expect,” “anticipate,” “estimate,” “project,” “target,” “goal,” “forecast,” and other terms of similar meaning that indicate future events and trends are also generally intended to identify forward-looking statements. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations, and involve risks and uncertainties. For us, these risks and uncertainties include, but are not limited to:

inability to maintain adequate liquidity to meet our operating cash flow requirements, repay maturing debt and meet other financial obligations;
economic downturns, cyclical demand for our products and insufficient demand for our products;
excess global capacity in the steel industry;
inability to successfully restructure our operations and/or invest in operations that will yield the best long-term value to our shareholders;
liability of our subsidiaries for claims alleging personal injury from exposure to asbestos-containing components historically used in certain products of our subsidiaries;
inability to obtain necessary capital or financing on satisfactory terms to acquire capital expenditures that may be necessary to support our growth strategy;
inoperability of certain equipment on which we rely;
increases in commodity prices or insufficient hedging against increases in commodity prices, reductions in electricity and natural gas supply or shortages of key production materials for us or our customers;
inability to satisfy the continued listing requirements of the New York Stock Exchange or the NYSE American Exchange;
potential attacks on information technology infrastructure and other cyber-based business disruptions;
fluctuations in the value of the U.S. dollar relative to other currencies;
changes in the existing regulatory environment;
consequences of pandemics and geopolitical conflicts;
work stoppage or another industrial action on the part of any of our unions;
failure to maintain an effective system of internal control;
changes in the global economic environment, inflation, elevated interest rates, recessions or prolonged periods of slow economic growth, and global instability and actual and threatened geopolitical conflict; and
those discussed more fully elsewhere in this report and in documents filed with the Securities and Exchange Commission by us, particularly in Item 1A, Risk Factors, in Part I of our Annual Report on Form 10-K for the year ended December 31, 2024.

We cannot guarantee any future results, levels of activity, performance or achievements. In addition, there may be events in the future that we are not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, we assume no obligation, and disclaim any obligation, to update forward-looking statements whether as a result of new information, events or otherwise.

22


 

The Business

The Corporation manufactures and sells highly engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments – the Forged and Cast Engineered Products (“FCEP”) segment and the Air and Liquid Processing (“ALP”) segment. This segment presentation is consistent with how the Corporation’s chief operating decision-maker evaluates financial performance and makes resource allocation and strategic decisions about the business.

The FCEP segment produces forged hardened steel rolls, cast rolls and forged engineered products (“FEP”). Forged hardened steel rolls are used primarily in hot and cold rolling mills by producers of steel, aluminum and other metals. Cast rolls, which are produced in a variety of iron and steel qualities, are used mainly in hot strip mills, medium/heavy section mills, roughing mills, and plate mills. FEP principally are sold to customers in the steel distribution market, oil and gas industry and the aluminum and plastic extrusion industries. The segment has operations in the United States, England, Sweden, and Slovenia, and an equity interest in three joint venture companies in China. Collectively, the segment primarily competes with European, Asian and North and South American companies in both domestic and foreign markets and distributes a significant portion of its products through sales offices located throughout the world.

The ALP segment includes Aerofin, Buffalo Air Handling and Buffalo Pumps, all divisions of Air & Liquid Systems Corporation (“Air & Liquid”), a wholly owned subsidiary of the Corporation. Aerofin produces custom-engineered finned tube heat exchange coils and related heat transfer products for a variety of industries including original equipment manufacturers and commercial, nuclear power generation and industrial manufacturing. Buffalo Air Handling produces large custom-designed air handling systems for institutional (e.g., hospital, university), pharmaceutical and general industrial building markets. Buffalo Pumps manufactures centrifugal pumps for the fossil-fueled power generation, marine defense and industrial refrigeration industries. The segment has operations in Virginia and New York with headquarters in Carnegie, Pennsylvania. The segment utilizes an independent group of sales offices located throughout the United States and Canada.

Executive Overview

For the FCEP segment, global steel manufacturing capacity continues to exceed global consumption of steel products. Demand for steel is soft but stable. Increased entry of low-priced products from other countries has negatively impacted local demand in the U.S. and Europe, with several of the segment’s largest customers engaging in trade cases to reduce the number of imports into the U.S. The U.S. government previously announced new tariffs on steel and aluminum imports to the U.S. and has, for now, removed the exceptions allowing certain countries to send un-tariffed products to the U.S. As of March 31, 2025, tariffs are now incurred on forged and cast rolls shipped from the segment's European facilities into the U.S. and on U.S. forged and cast rolls shipped into China. Since the cast roll market is currently underserved in the U.S., the Corporation believes the segment's European operations are on equal footing with its competition with respect to tariffs. It is expected that the costs associated with tariffs will be passed on to customers. Tariff outcomes are fluid and subject to change. Accordingly, it is difficult to predict how tariffs will affect the ordering patterns of the segment's customers, however, customer deferral of orders is expected.

The primary focus for the FCEP segment is to improve its profitability by maintaining a strong position in the roll market and continuing to improve operational efficiency and equipment reliability following the completion of a significant capital equipment program. In addition, in February 2025, the segment's U.K. operations entered into a formal consultation process with its unions and staff to evaluate various options to improve its profitability, which continues as of March 31, 2025.

For the ALP segment, businesses are benefiting from steady demand and increased market share but continue to face increasing production costs due to inflation. The segment has been implementing price increases for certain of its products to help mitigate these inflationary effects. The focus for this segment is to grow revenues, strengthen engineering and manufacturing capabilities to keep pace with growth opportunities, and continue to improve its sales distribution network. As of March 31, 2025, tariffs are now incurred on certain of the segment's raw materials. It is expected that the costs associated with these tariffs will be passed on to customers. Tariff outcomes are fluid and subject to change; however, the U.S.'s onshoring of additional manufacturing capabilities would potentially increase demand for the segment's products.

The Corporation is actively monitoring, and will continue to actively monitor, changes prompted by the U.S. government, repercussions from the Russia-Ukraine and Middle East conflicts and similar geopolitical matters, economic conditions, and other developments relevant to its business including the potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.

23


 

Selected Financial Information

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

 

Change

 

Net Sales:

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

$

72,287

 

 

$

77,189

 

 

$

(4,902

)

Air and Liquid Processing

 

 

31,978

 

 

 

33,026

 

 

 

(1,048

)

Consolidated

 

$

104,265

 

 

$

110,215

 

 

$

(5,950

)

 

 

 

 

 

 

 

 

 

 

Income from Operations:

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

$

3,905

 

 

$

1,576

 

 

$

2,329

 

Air and Liquid Processing

 

 

3,494

 

 

 

1,982

 

 

 

1,512

 

Corporate costs

 

 

(3,549

)

 

 

(3,476

)

 

 

(73

)

Consolidated

 

$

3,850

 

 

$

82

 

 

$

3,768

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2025

 

 

December 31,
2024

 

 

Change

 

Backlog:

 

 

 

 

 

 

 

 

 

Forged and Cast Engineered Products

 

$

232,296

 

 

$

250,530

 

 

$

(18,234

)

Air and Liquid Processing

 

 

136,157

 

 

 

128,354

 

 

 

7,803

 

Consolidated

 

$

368,453

 

 

$

378,884

 

 

$

(10,431

)

Net sales approximated $104,265 and $110,215 for the three months ended March 31, 2025 and 2024, respectively, a decrease of $5,950. A discussion of net sales for the Corporation’s two segments is included below.

Income from operations approximated $3,850 and $82 for the three months ended March 31, 2025 and 2024, respectively, an improvement of $3,768. A discussion of income from operations for the Corporation’s two segments is included below.

Backlog equaled $368,453 as of March 31, 2025 versus $378,884 as of December 31, 2024. Backlog represents the accumulation of firm orders on hand which: (i) are supported by evidence of a contractual arrangement, (ii) include a fixed and determinable sales price, (iii) have reasonably assured collectability, and (iv) generally are expected to ship within two years from the backlog reporting date. Backlog at a certain date may not be a direct measure of future revenue for a particular order because price increases, negotiated subsequently to the original order, are not included in backlog until the updated contract is received from the customer and certain surcharges are not determinable until the order is complete and ready for shipment to the customer. Approximately 20% of the backlog is expected to be released after 2025. A discussion of backlog by segment is included below.

Costs of products sold, excluding depreciation and amortization, as a percentage of net sales, for the three months ended March 31, 2025 and 2024 approximated 78.7% and 83.9%, respectively, with gross margins improving for both the FCEP and ALP segments. See further discussion in the commentary for the Corporation’s two segments below.

Selling and administrative expenses approximated $13,659 and $12,973 for the three months ended March 31, 2025 and 2024, respectively. The increase in selling and administrative expenses for the current year period when compared to the same period of the prior year is primarily due to inflationary increases, higher employee-related costs and professional fees.

Interest expense for the three months ended March 31, 2025 and 2024 was comparable and approximated $2,726 and $2,757, respectively. More specifically:

Lower average interest rates for 2025 versus 2024 decreased interest expense by approximately $200 for the three months ended March 31, 2025; and
Lower average borrowings outstanding under the revolving credit facility decreased interest expense by approximately $159 for the three months ended March 31, 2025; offset by
Higher average borrowings under the equipment financing facility, net of capitalized interest, increased interest expense by approximately $353 for the three months ended March 31, 2025.

24


 

Other income – net is comprised of the following:

 

 

Three Months Ended March 31,

 

 

 

2025

 

2024

 

Change

 

Net pension and other postretirement income

 

$

665

 

$

1,179

 

$

(514

)

Gain (loss) on foreign exchange transactions

 

 

221

 

 

(492

)

 

713

 

Unrealized (loss) gain on Rabbi trust investments

 

 

(89

)

 

222

 

 

(311

)

Investment income

 

 

24

 

 

19

 

 

5

 

Other

 

 

5

 

 

(5

)

 

10

 

 

 

$

826

 

$

923

 

$

(97

)

Other income – net fluctuated primarily due to:

Lower net pension and other postretirement income primarily due to a lower expected long-term rate of return on the assets of U.S. defined benefit pension plan in 2025 versus 2024,
Changes in foreign exchange gains and losses, and
Changes in unrealized losses and gains in the market value of the Rabbi trust investments corresponding to the volatility in the financial markets.

Income tax provision for each of the periods includes income taxes associated with the Corporation’s profitable operations. An income tax benefit is not able to be recognized on losses of certain of the Corporation’s entities since it is “more likely than not” the asset will not be realized. Accordingly, changes in the income tax provision for each of the periods include the effects of changes in the pre-tax income of the Corporation’s profitable operations in each jurisdiction and changes in expectations as to whether an income tax benefit will be able to be realized for the deferred income tax assets recognized.

The income tax provision for the three months ended March 31, 2025 includes an income tax benefit of approximately $500 resulting from the Corporation's majority-owned Chinese joint venture qualifying as a high-tech enterprise (“HTE”). As an HTE, the earnings of the Chinese joint venture through 2026 will be taxed at a rate of 15% (versus 25%) and, at March 31, 2025, certain net deferred income tax liabilities were revalued at a rate of 15% (versus 25%) thereby reducing deferred income tax liabilities and contributing to the income tax benefit.

Valuation allowances are recorded against the majority of the Corporation’s deferred income tax assets. The Corporation will maintain the valuation allowances until there is sufficient evidence to support the reversal of all or some portion of the allowances. Given the Corporation’s current earnings and anticipated future earnings in Sweden, the Corporation believes there is a reasonable possibility within the next 12 months, sufficient positive evidence may become available to allow the Corporation to conclude some portion of the valuation allowance will no longer be needed. Release of any portion of the valuation allowance would result in the recognition of deferred income tax assets on the Corporation’s condensed consolidated balance sheet and a decrease to the Corporation’s income tax expense in the period the release is recorded. The exact timing and the amount of the valuation allowance released are subject to, among many items, the level of profitability achieved. Once the valuation allowance is completely reversed, a tax provision would be recognized on future earnings.

Net income (loss) attributable to Ampco-Pittsburgh and net income (loss) per common share attributable to Ampco-Pittsburgh equaled $1,142 and $0.06 per common share and $(2,717) and $(0.14) per common share for the three months ended March 31, 2025 and 2024, respectively. The income tax benefit resulting from the Corporation's majority-owned Chinese joint venture qualifying as an HTE of approximately $500 improved net income attributable to Ampco-Pittsburgh and net income per common share attributable to Ampco-Pittsburgh by approximately $299 and $0.01 per common share, respectively, for the three months ended March 31, 2025.

25


 

Net Sales and Operating Results by Segment

Forged and Cast Engineered Products

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

 

Change

 

Net Sales:

 

 

 

 

 

 

 

 

 

Forged and cast mill rolls

 

$

68,622

 

 

$

73,396

 

 

$

(4,774

)

FEP

 

 

3,665

 

 

 

3,793

 

 

 

(128

)

 

 

$

72,287

 

 

$

77,189

 

 

$

(4,902

)

 

 

 

 

 

 

 

 

 

 

Income from Operations

 

$

3,905

 

 

$

1,576

 

 

$

2,329

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2025

 

 

December 31,
2024

 

 

Change

 

Backlog

 

$

232,296

 

 

$

250,530

 

 

$

(18,234

)

The decline in net sales for the three months ended March 31, 2025, when compared to the same period of the prior year, is primarily due to the following:

Lower volume and changes in product mix for roll sales, which decreased net sales by approximately $6,300 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024;
Changes in exchange rates between the periods used to translate net sales of the Corporation’s foreign subsidiaries into the U.S. dollar, which decreased net sales by approximately $1,000 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; and
Lower FEP sales, which decreased net sales by approximately $100 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; offset
Higher base pricing, net of lower variable-index surcharges passed through to customers as a result of lower prices for raw material, energy and transportation, which increased net sales by approximately $2,500 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024.

Income from operations for the three months ended March 31, 2025 increased when compared to the three months ended March 31, 2024 primarily due to:

Benefit from improved pricing and changes in manufacturing costs, net of lower variable-index surcharges, which increased income from operations by approximately $5,200 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; and
Better manufacturing absorption for the current year period, which increased operating income by approximately $500 for the three months ended March 31, 2025, when compared to the three months ended March 31, 2024, primarily as a result of operational efficiencies and improved equipment reliability following completion of a significant capital equipment program by the end of 2024 coupled with lower absorption in the prior year period as a result of a fire at one of the Corporation’s cast roll facilities; offset by
Lower volume of shipments, which decreased operating income by approximately $2,600 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024;
Higher selling and administrative costs, which decreased operating income by approximately $700 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; and
Changes in exchange rates between the periods used to translate the operating results of the Corporation’s foreign subsidiaries into the U.S. dollar, which reduced income from operations by approximately $100 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024.

Backlog decreased at March 31, 2025 from December 31, 2024 by $18,234 primarily due to:

Lower backlog for mill rolls of approximately $31,700 due to (i) lower demand in Europe as a result of mills operating at a reduced rate, (ii) U.S. customers deferring orders due, in part, to the current geopolitical events with tariffs and uncertainty as to the total cost of a roll, and (iii) timing of orders for the following year; offset by Higher exchange rates used to translate the backlog of the Corporation’s foreign subsidiaries into the U.S. dollar, which increased backlog at March 31, 2025 when compared to backlog at December 31, 2024, by approximately $8,200; and

26


 

Improved demand for FEP, which increased backlog at March 31, 2025 when compared to backlog at December 31, 2024 by approximately $5,200.

 

At March 31, 2025, approximately 14% of backlog is expected to ship after 2025.

Air and Liquid Processing

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

 

Change

 

Net Sales:

 

 

 

 

 

 

 

 

 

Air handling systems

 

$

10,628

 

 

$

12,510

 

 

$

(1,882

)

Heat exchange coils

 

 

11,525

 

 

 

10,823

 

 

 

702

 

Centrifugal pumps

 

 

9,825

 

 

 

9,693

 

 

 

132

 

 

 

$

31,978

 

 

$

33,026

 

 

$

(1,048

)

 

 

 

 

 

 

 

 

 

 

Income from Operations

 

$

3,494

 

 

$

1,982

 

 

$

1,512

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,
2025

 

 

December 31,
2024

 

 

Change

 

Backlog

 

$

136,157

 

 

$

128,354

 

 

$

7,803

 

The decrease in net sales for the three months ended March 31, 2025, when compared to the same period of the prior year period, is primarily due to:

Lower net sales of air handling units principally due to the timing of shipments and associated revenue recognition, which reduced net sales by approximately $1,900 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; offset by
Higher net sales of heat exchange coils principally due to an increase in the volume of shipments to nuclear-power customers, which increased net sales by approximately $700 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024; and
Higher net sales of centrifugal pumps principally due to higher sales to the U.S. Navy after-market and commercial customers, which increased net sales by approximately $100 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024.

The improvement in operating income is principally due to changes in product mix, offset in part by the lower volume of shipments and higher manufacturing costs, which had a net benefit to operating income of approximately $1,500 for the three months ended March 31, 2025 when compared to the three months ended March 31, 2024.

Backlog at March 31, 2025 improved when compared to backlog December 31, 2024 by approximately $7,800 with each of the product lines improving. In particular, backlog for:

Heat exchange coils increased approximately $4,500 primarily due to record order intake in the nuclear market;
Centrifugal pumps increased approximately $1,900 primarily due to strong order activity in the U.S. Navy market; and
Air handling units increased approximately $1,400 primarily due to strong order activity in the pharmaceutical market.

At March 31, 2025, approximately 31% of backlog is expected to ship after 2025.

Non-GAAP Financial Measures

The Corporation presents non-GAAP adjusted EBITDA and non-GAAP adjusted income (loss) from operations. Non-GAAP adjusted EBITDA is calculated as net income (loss) excluding interest expense, other income - net, income tax provision, depreciation and amortization, and stock-based compensation along with significant charges or credits that are one-time charges or credits, unrelated to the Corporation’s ongoing results of operations, or beyond its control. Non-GAAP adjusted income (loss) from operations is calculated as income (loss) from operations excluding depreciation and amortization and stock-based compensation along with significant charges or credits that are one-time charges or credits, unrelated to the segment’s ongoing results of operations, or beyond its control.

27


 

These non-GAAP financial measures are not based on any standardized methodology prescribed by accounting principles generally accepted in the United States of America (“GAAP”).

Beginning in 2025, the Corporation began presenting non-GAAP adjusted EBITDA along with non-GAAP adjusted income (loss) from operations. These measures are key measures used by the Corporation's management and Board of Directors to understand and evaluate the operating performance of the Corporation and its segments. While these non-GAAP measures may not be directly comparable to similarly titled measures presented by other companies, the Corporation's management and Board of Directors believe these non-GAAP measures enhance comparability to companies in its stated industry peer group.

The Corporation believes these non-GAAP financial measures help identify underlying trends in its business that otherwise could be masked by the effect of the items it excludes from adjusted EBITDA and adjusted income (loss) from operations. The Corporation also believes these non-GAAP financial measures provide useful information to management, shareholders and investors, and others in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects and allowing for greater transparency with respect to key financial metrics used by the Corporation’s management in its financial and operational decision-making.

Non-GAAP adjusted EBITDA and non-GAAP adjusted income (loss) from operations are not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are limitations related to the use of non-GAAP adjusted EBITDA, rather than net income (loss), or non-GAAP adjusted income (loss) from operations, rather than income (loss) from operations, which are the nearest GAAP equivalents.

The following is a reconciliation of net income (loss) to non-GAAP adjusted EBITDA for the three months ended March 31, 2025 and 2024, respectively:

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Net income (loss) (GAAP)

 

$

1,891

 

 

$

(2,206

)

Add (deduct):

 

 

 

 

 

 

Interest expense

 

 

2,726

 

 

 

2,757

 

Other income – net

 

 

(826

)

 

 

(923

)

Income tax provision

 

 

59

 

 

 

454

 

Income from operations (GAAP)

 

 

3,850

 

 

 

82

 

Add:

 

 

 

 

 

 

Depreciation and amortization

 

 

4,636

 

 

 

4,670

 

Stock-based compensation

 

 

306

 

 

 

346

 

Adjusted EBITDA (Non-GAAP)

 

$

8,792

 

 

$

5,098

 

 

 

 

 

 

 

 

 

The following is a reconciliation of income (loss) from operations to non-GAAP adjusted income (loss) from operations for the three months ended March 31, 2025 and 2024, respectively:

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

 

FCEP

 

ALP

 

Corporate (1)

 

Consolidated

 

 

FCEP

 

ALP

 

Corporate (1)

 

Consolidated

 

Income (loss) from operations (GAAP)

$

3,905

 

$

3,494

 

$

(3,549

)

$

3,850

 

 

$

1,576

 

$

1,982

 

$

(3,476

)

$

82

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

4,368

 

 

268

 

 

 

 

4,636

 

 

 

4,430

 

 

240

 

 

 

 

4,670

 

Stock-based compensation

 

 

 

 

 

306

 

 

306

 

 

 

 

 

 

 

346

 

 

346

 

Income (loss) from operations, as adjusted (Non-GAAP)

$

8,273

 

$

3,762

 

$

(3,243

)

$

8,792

 

 

$

6,006

 

$

2,222

 

$

(3,130

)

$

5,098

 

 

(1)
Corporate represents the operating expenses of the corporate office and other costs not allocated to the segments.

28


 

Liquidity and Capital Resources

 

 

Three Months Ended March 31,

 

 

 

2025

 

2024

 

Change

 

Net cash flows (used in) provided by operating activities

 

$

(5,280

)

$

4,535

 

$

(9,815

)

Net cash flows used in investing activities

 

 

(1,711

)

 

(2,845

)

 

1,134

 

Net cash flows (used in) provided by financing activities

 

 

(1,727

)

 

2,028

 

 

(3,755

)

Effect of exchange rate changes on cash and cash equivalents

 

 

420

 

 

(175

)

 

595

 

Net (decrease) increase in cash and cash equivalents

 

 

(8,298

)

 

3,543

 

 

(11,841

)

Cash and cash equivalents at beginning of period

 

 

15,427

 

 

7,286

 

 

8,141

 

Cash and cash equivalents at end of period

 

$

7,129

 

$

10,829

 

$

(3,700

)

Net cash flows (used in) provided by operating activities equaled $(5,280) and $4,535 for the three months ended March 31, 2025 and 2024, respectively, a change of $(9,815) primarily due to:

Higher investment in trade working capital of approximately $12,700; and
Higher contributions to the U.S. defined benefit pension plan of approximately $796; offset by
Net income of $1,891 for the three months ended March 31, 2025 versus a net loss of $2,206 for the three months ended March 31, 2024; and
Lower net asbestos-related payments of $1,254 for the three months ended March 31, 2025 versus the three months ended March 31, 2024.

Trade receivables at March 31, 2025 increased by approximately $11,900 when compared to trade receivables at December 31, 2024 primarily due to:

Higher sales in February and March of 2025 versus November and December of 2024, which increased trade receivables at March 31, 2025 when compared to December 31, 2024 by approximately $9,300, and
Higher exchange rates used to translate the trade receivables of the Corporation’s foreign subsidiaries into the U.S. dollar, which increased trade receivables at March 31, 2025 when compared to December 31, 2024 by approximately $1,200.

Inventories at March 31, 2025 increased by approximately $7,400 when compared to inventories at December 31, 2024 primarily due to:

Higher in-process and finished goods inventories at March 31, 2025 versus December 31, 2024 of approximately $5,000 resulting from higher production in anticipation of planned summer shutdowns and more production days in the first quarter of a year versus the fourth quarter of a year;
Higher exchange rates used to translate the inventories of the Corporation’s foreign subsidiaries into the U.S. dollar, which increased inventories at March 31, 2025 when compared to December 31, 2024 by approximately $2,300; and
Timing of shipments and associated revenue recognition, particularly for air handling units which increased inventories at March 31, 2025 when compared to December 31, 2024 by approximately $1,600; offset by
Lower raw material inventories at March 31, 2025 when compared to December 31, 2024 of approximately $1,600 principally due to the timing of production.

 

Accounts payable at March 31, 2025 increased by approximately $5,000 when compared to accounts payable at December 31, 2024 primarily due to timing of payments, and higher exchange rates used to translate the accounts payable of the Corporation’s foreign subsidiaries into the U.S. dollar which increased accounts payables at March 31, 2025 when compared to December 31, 2024 by approximately $1,100.

Asbestos-related payments are expected to continue in the foreseeable future. The amount of asbestos-related payments and corresponding insurance recoveries are difficult to predict and can vary based on a number of factors, including changes in assumptions, as outlined in Note 15 to the condensed consolidated financial statements.

 

Net cash flows used in investing activities equaled $(1,711) and $(2,845) for the three months ended March 31, 2025 and 2024, respectively, a change of $1,134 which is primarily due to:

Lower capital spend of approximately $1,100 by the FCEP segment primarily due to the completion of a significant capital equipment program during the second quarter of 2024; offset by Higher capital spend of approximately $500 by the ALP segment.

29


 

Certain of this capital spend may be able to be subsidized by various government incentives such as grants. For the three months ended March 31, 2025, the Corporation received approximately $323 in government incentives. To date, no repayment obligations exist for any government incentive received.

 

At March 31, 2025, commitments for future capital expenditures approximated $5,200 which are expected to be spent over the next 12-18 months.

Net cash flows (used in) provided by financing activities equaled $(1,727) and $2,028 for the three months ended March 31, 2025 and 2024, respectively, a change of $(3,755) which is primarily due to:

Higher net repayments on the Corporation’s revolving credit facility of $2,955;
No proceeds from the equipment financing facility in the current year, due to the completion of a significant capital equipment program during the second quarter of 2024, whereas the prior year included proceeds from the equipment financing facility of $1,134; and
Higher principal payments of $330 in the current year, primarily on the equipment financing facility; offset by
Prior year repayment of related-party debt of $664.

The effect of exchange rate changes on cash and cash equivalents is primarily attributable to the fluctuation of the British pound and Swedish krona against the U.S. dollar.

As a result of the above, cash and cash equivalents decreased by $8,298 during 2025 and ended the period at $7,129 in comparison to $15,427 at December 31, 2024. The majority of the Corporation’s cash and cash equivalents is held by its foreign operations. Domestic customer remittances are used to repay borrowings under the Corporation’s revolving credit facility daily, resulting in minimal cash maintained by the Corporation’s domestic operations. Cash held by the Corporation’s foreign operations is considered to be permanently re-invested; accordingly, a provision for estimated local and withholding tax has not been made. If the Corporation were to remit any foreign earnings to it or any of its U.S. entities, the estimated tax impact would be insignificant.

Funds on hand, funds generated from future operations and availability under the Corporation’s revolving credit facility are expected to be sufficient to finance the Corporation’s operational requirements, debt service costs and capital expenditures. As of March 31, 2025, remaining availability under the revolving credit facility approximated $28,586, net of standard availability reserves. Since a significant portion of the Corporation’s debt includes variable rate interest, increases in the underlying benchmark rates will increase the Corporation’s debt service costs. Similarly, decreases in the underlying benchmark rates will decrease the Corporation’s debt service costs.

The maturity date for the revolving credit facility is June 29, 2026 and, subject to the other terms and conditions of the revolving credit agreement, will become due on that date. However, the Corporation is currently in discussions with its lenders with the intent of securing a mutually beneficial arrangement covering multiple years prior to June 30, 2025. Additionally, while the Corporation anticipates it has sufficient liquidity to finance the Corporation’s operational requirements, debt service costs and capital expenditures, it may from time to time consider alternatives, potential transactions and other strategies in an attempt to enhance its liquidity. Given such measures are forward-looking, the Corporation cannot ensure it will be successful in renegotiating its revolving credit facility or achieving such enhancements to improve its liquidity.

Litigation and Environmental Matters

See Note 15 and Note 16 to the condensed consolidated financial statements.

Critical Accounting Policies

The Corporation’s critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2024, remain unchanged.

Recently Issued Accounting Pronouncements

See Note 1 to the condensed consolidated financial statements.

30


 

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4 – CONTROLS AND PROCEDURES

Disclosure controls and procedures. An evaluation of the effectiveness of the Corporation’s disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission (“SEC”) rules as controls and other procedures designed to ensure information required to be disclosed by a company in the reports it files under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure information required to be disclosed by an issuer in the reports it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation’s management, including the principal executive officer and principal financial officer, has concluded the Corporation’s disclosure controls and procedures were effective as of March 31, 2025.

Changes in internal control. There has been no change in the Corporation’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

31


 

 

PART II – OTHER INFORMATION

AMPCO-PITTSBURGH CORPORATION

The information contained in Note 15 to the condensed consolidated financial statements (Litigation) is incorporated herein by reference.

Item 1A Risk Factors

There are no material changes to the “Risk Factors” included under Item 1A of the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2024. These “Risk Factors” should be carefully considered, understanding such risk factors may not describe every risk facing the Corporation. Additional risks and uncertainties not currently known to the Corporation or that the Corporation currently deems to be immaterial could adversely affect its business, financial condition and results of operations in the future.

Items 2-4 None.

Item 5 Other Information

(a) None.

(b) None.

(c) During the three months ended March 31, 2025, no director or officer of the Corporation adopted or terminated a 'Rule 10b5-1 trading arrangement' or 'non-Rule 10b5-1 trading arrangement,' with each term being defined in Item 408(a) of Regulation S-K.

 

32


 

Item 6 Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Form 10-Q.

 

 

 

 

 

(3.1)

 

 

 

Restated Articles of Incorporation, effective as of August 11, 2017, incorporated by reference to Quarterly Report on Form 10-Q filed on November 9, 2017.

 

 

 

 

 

(3.2)

 

 

 

Amendment of Amended and Restated Articles of Incorporation, effective as of May 9, 2019, incorporated by reference to Quarterly Report on Form 10-Q filed on May 10, 2019.

 

 

 

 

 

 

(3.3)

 

 

 

Amended and Restated By-Laws, effective June 4, 2024, incorporated by reference to Quarterly Report on Form 10-Q filed on August 12, 2024.

 

 

 

 

 

(10.1)

 

†+

 

Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan (as Amended and Restated).

 

 

 

 

 

(31.1)

 

 

Certification of Principal Executive Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.

 

 

 

 

 

(31.2)

 

 

Certification of Principal Financial Officer pursuant to Section 302 of The Sarbanes-Oxley Act of 2002.

 

 

 

 

 

(32.1)

 

††

 

Certification of Principal Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.

 

 

 

 

 

(32.2)

 

††

 

Certification of Principal Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.

 

 

 

 

 

(101.INS)

 

*

 

Inline XBRL Instance Document

 

 

 

 

 

(101.SCH)

 

**

 

Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Document

 

 

 

 

 

(104)

 

 

 

The cover page for the Corporation’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101.

 

 

 

Filed herewith.

††

 

 

 

Furnished herewith.

+

 

 

 

Management contracts, compensatory plans or arrangements required to be filed as an exhibit hereto pursuant to Item 601 of Regulation S-K.

*

 

 

 

The instance document does not appear in the Interactive Data File because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.

**

 

 

 

Attached as Exhibit 101 to this report are the following documents formatted in Inline XBRL: (i) the Condensed Consolidated Balance Sheets at March 31, 2025 and December 31, 2024, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024, (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2025 and 2024, (iv) the Condensed Consolidated Statements of Shareholders' Equity for the three months ended March 31, 2025 and 2024, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024, and (vi) Notes to Condensed Consolidated Financial Statements.

33


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

AMPCO-PITTSBURGH CORPORATION

 

 

 

 

 

DATE: May 12, 2025

 

BY:

 

/s/ J. Brett McBrayer

 

 

 

 

J. Brett McBrayer

 

 

 

 

Director and Chief Executive Officer

 

 

 

 

 

DATE: May 12, 2025

 

BY:

 

/s/ Michael G. McAuley

 

 

 

 

Michael G. McAuley

 

 

 

 

Senior Vice President, Chief Financial Officer and Treasurer

 

34


EX-10.1 2 ap-ex10_1.htm EX-10.1 EX-10.1

Exhibit 10.1

AMPCO-PITTSBURGH CORPORATION
2016 OMNIBUS INCENTIVE PLAN
(AS AMENDED AND RESTATED AS OF MAY 13, 2021, MAY 18, 2023 AND MAY 8, 2025)

Ampco-Pittsburgh Corporation, a Pennsylvania corporation, sets forth herein the terms of its 2016 Omnibus Incentive Plan, as follows:

1. PURPOSE

The Plan is intended to enhance the Company’s and its Subsidiaries’ ability to attract and retain employees, Consultants and Non-Employee Directors, and to motivate such employees, Consultants and Non-Employee Directors to serve the Company and its Subsidiaries and to expend maximum effort to improve the business results and earnings of the Company, by providing to such persons an opportunity to acquire or increase a direct proprietary interest in the operations and future success of the Company. To this end, the Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards and cash awards. Any of these awards may, but need not, be made as performance incentives to reward attainment of performance goals in accordance with the terms hereof. Stock options granted under the Plan may be non-qualified stock options or incentive stock options, as provided herein. Upon becoming effective, the Plan replaces, and no further awards shall be made under, the Predecessor Plan.

2. DEFINITIONS

For purposes of interpreting the Plan and related documents (including Award Agreements), the following definitions shall apply:

2.1. “Annual Incentive Award” means a cash-based Performance Award with a performance period that is the Company’s fiscal year or other 12-month (or shorter) performance period as specified under the terms of the Award as approved by the Committee.

2.2. “Award” means a grant of an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Other Stock-Based Award or cash award under the Plan.

2.3. “Award Agreement” means a written agreement between the Company and a Grantee, or notice from the Company or a Subsidiary to a Grantee that evidences and sets out the terms and conditions of an Award.

2.4. “Board” means the Board of Directors of the Company.

2.5. “Change in Control” shall have the meaning set forth in Section 15.3.2.

2.6. “Code” means the Internal Revenue Code of 1986, as in effect as of the Third Restatement Effective Date or as hereafter amended. References to the Code shall include the valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder.

2.7. “Committee” means the Compensation Committee of the Board or any committee or other person or persons designated by the Board to administer the Plan. The Board will cause the Committee to satisfy the applicable requirements of any stock exchange on which the Common Stock may then be listed. For purposes of Awards intended to constitute “performance-based compensation” under Prior Section 162(m), to the extent required by Prior Section 162(m), Committee means all of the members of the Committee who are “outside directors” within the meaning of Prior Section 162(m). For purposes of Awards to Grantees who are subject to Section 16 of the Exchange Act, Committee means all of the members of the Committee who are “non-employee directors” within the meaning of Rule 16b-3 adopted under the Exchange Act. All references in the Plan to the Board shall mean such Committee or the Board.

2.8. “Company” means Ampco-Pittsburgh Corporation, a Pennsylvania corporation, or any successor corporation.

2.9. “Company’s Voting Securities” means the combined voting power of all outstanding voting securities of the Company entitled to vote generally in the election of directors to the Board.

1


 

2.10. “Common Stock” or “Stock” means a share of Common Stock of the Company, par value $1.00 per share.

2.11. “Consultant” means (i) with respect to any Award granted to a consultant or advisor, intended to be registered on Form S-8 under the Securities Act, any consultant or advisor eligible to receive an award thereunder pursuant to General Instruction A.1(a)(1) or (ii) with respect to any other Award, any Person, except an employee or Non-Employee Director, engaged by the Company or any Subsidiary, to render services to such entity, including as an advisor, pursuant to the terms of a written agreement.

2.12. “Corporate Transaction” means a reorganization, merger, statutory share exchange, consolidation, sale of all or substantially all of the Company’s assets, or the acquisition of assets or stock of another entity by the Company, or other corporate transaction involving the Company or any of its Subsidiaries.

2.13. “Effective Date” means May 5, 2016, the date the Plan was initially approved by the Company’s shareholders.

2.14. “Exchange Act” means the Securities Exchange Act of 1934, as in effect as of the Third Restatement Effective Date or as hereafter amended.

2.15. “Fair Market Value” of a share of Common Stock as of a particular date shall mean (i) if the Common Stock is listed on a national securities exchange, the closing or last price of the Common Stock on the composite tape or other comparable reporting system for the applicable date, or if the applicable date is not a trading day, the trading day immediately preceding the applicable date, or (ii) if the shares of Common Stock are not then listed on a national securities exchange, the closing or last price of the Common Stock quoted by an established quotation service for over-the-counter securities, or (iii) if the shares of Common Stock are not then listed on a national securities exchange or quoted by an established quotation service for over-the-counter securities, or the value of such shares is not otherwise determinable, such value as determined by the Board in good faith in its sole discretion.

2.16. “Family Member” means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law, or sister-in-law, including adoptive relationships, of the applicable individual, any person sharing the applicable individual’s household (other than a tenant or employee), a trust in which any one or more of these persons have more than fifty percent of the beneficial interest, a foundation in which any one or more of these persons (or the applicable individual) control the management of assets, and any other entity in which one or more of these persons (or the applicable individual) own more than fifty percent of the voting interests.

2.17. “First Restatement Effective Date” means May 13, 2021.

2.18. “Grant Date” means, as determined by the Board, the latest to occur of (i) the date as of which the Board approves an Award, (ii) the date on which the recipient of an Award first becomes eligible to receive an Award under Section 6hereof, or (iii) such other date as may be specified by the Board in the Award Agreement.

2.19. “Grantee” means a person who receives or holds an Award under the Plan.

2.20. “Incentive Stock Option” means an “incentive stock option” within the meaning of Section 422 of the Code, or the corresponding provision of any subsequently enacted tax statute, as amended from time to time.

2.21. “Non-Employee Director” means a member of the Board who is not an employee.

2.22. “Non-qualified Stock Option” means an Option that is not an Incentive Stock Option.

2.23. “Other Stock-based Award” means Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, other than Options, Stock Appreciation Rights, Restricted Stock, and Restricted Stock Units.

2.24. “Option” means an option to purchase one or more shares of Stock pursuant to the Plan.

2.25. “Option Price” means the exercise price for each share of Stock subject to an Option.

2


 

2.26. “Outstanding Common Stock” means, at any time, the issued and outstanding shares of Common Stock.

2.27. “Performance Award” means an Award made subject to the attainment of performance goals (as described in Section 12) over a performance period established by the Committee, and includes an Annual Incentive Award.

2.28.“Person” shall mean an individual, any general partnership, limited partnership, limited liability company, corporation, trust, business trust, joint stock company, joint venture, unincorporated association, cooperative or association or any other legal entity or organization of whatever nature, and shall include any successor (by merger or otherwise) of such entity, or a government or any agency or political subdivision thereof.

2.29. “Plan” means this Ampco-Pittsburgh Corporation 2016 Omnibus Incentive Plan, as amended from time to time.

2.30. “Predecessor Plan” means the Ampco-Pittsburgh Corporation 2011 Omnibus Incentive Plan.

2.31. “Prior Section 162(m)” shall mean Section 162(m) of the Code as in effect prior to its amendment by the Tax Cuts and Jobs Act, P.L. 115-97, including the regulations and guidance promulgated in respect of Section 162(m) of the Code as in effect prior to such amendment.

2.32. “Purchase Price” means the purchase price for each share of Stock pursuant to a grant of Restricted Stock.

2.33. “Restricted Stock” means shares of Stock, awarded to a Grantee pursuant to Section 10hereof.

2.34. “Restricted Stock Unit” means a bookkeeping entry representing the equivalent of shares of Stock, awarded to a Grantee pursuant to Section 10 hereof.

2.35. “Restriction Period” shall have the meaning set forth in Section 10.1.

2.36. “SAR Exercise Price” means the per share exercise price of a SAR granted to a Grantee under Section 9 hereof.

2.37. “Section 162(m) Grandfather” shall mean the regulations or other guidance promulgated in respect of transition rules under Section 162(m) of the Code, as Section 162(m) of the Code is in effect from time to time on or after the amendment and restatement of the Plan as of the Third Restatement Effective Date, extending the deductibility of Awards intended to be “qualified performance-based compensation” under Prior Section 162(m).

2.38. “Section 409A” means Section 409A of the Code.

2.39. “Securities Act” means the Securities Act of 1933, as in effect as of the Third Restatement Effective Date or as hereafter amended.

2.40. “Separation from Service” means a termination of Service by a Service Provider, as determined by the Board, which determination shall be final, binding and conclusive; provided if any Award governed by Section 409A is to be distributed on a Separation from Service, then the definition of Separation from Service for such purposes shall comply with the definition provided in Section 409A.

2.41. “Service” means service as a Service Provider to the Company or an Subsidiary. Unless otherwise stated in the applicable Award Agreement, a Grantee’s change in position or duties shall not result in interrupted or terminated Service, so long as such Grantee continues to be a Service Provider to the Company or an Subsidiary.

2.42. “Service Provider” means an employee, Non-Employee Director or Consultant.

2.43. “Stock Appreciation Right” or “SAR” means a right granted to a Grantee under Section 9 hereof.

3


 

2.44. “Subsidiary” means with respect to any Person, any entity of which (i) a majority of the total voting power of shares of stock or equivalent ownership interests entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, trustees or other members of the applicable governing body thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (ii) if no such governing body exists at such entity, a majority of the total voting power of shares of stock or equivalent ownership interests of the entity is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability company, partnership, association or other similar business entity if such Person or Persons shall be allocated a majority of limited liability company, partnership, association or such other business entity gains or losses or shall be or control the managing member or general partner of such limited liability company, partnership, association or such other business entity.

2.45. “Substitute Award” means any Award granted in assumption of or in substitution for an award of a company or business acquired by the Company or a Subsidiary or with which the Company or an Subsidiary combines.

2.46. “Ten Percent Shareholder” means an individual who owns more than ten percent (10%) of the total combined voting power of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Section 424(d) of the Code shall be applied.

2.47. “Termination Date” means the date that is ten (10) years after the Third Restatement Effective Date, unless the Plan is earlier terminated by the Board under Section 5.2 hereof.

2.48. “Third Restatement Effective Date” means March 6, 2025, the date the Plan, as amended and restated, was approved by the Company's Board.

3. ADMINISTRATION OF THE PLAN

3.1. General.

The Board shall have such powers and authorities related to the administration of the Plan as are consistent with the Company’s articles of incorporation and bylaws and applicable law. The Board shall have the power and authority to delegate its powers and responsibilities hereunder to the Committee, which shall have full authority to act in accordance with its charter, and with respect to the authority of the Board to act hereunder, all references to the Board shall be deemed to include a reference to the Committee, to the extent such power or responsibilities have been delegated. Except as specifically provided in Section 14or as otherwise may be required by applicable law, regulatory requirement or the articles of incorporation or the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations not inconsistent with the specific terms and provisions of the Plan that the Board deems to be necessary or appropriate to the administration of the Plan. The Committee shall administer the Plan; provided that, the Board shall retain the right to exercise the authority of the Committee to the extent consistent with applicable law and the applicable requirements of any securities exchange on which the Common Stock may then be listed. The interpretation and construction by the Board of any provision of the Plan, any Award or any Award Agreement shall be final, binding and conclusive. Without limitation, the Board shall have full and final authority, subject to the other terms and conditions of the Plan, to:

(i) designate Grantees;

(ii) determine the type or types of Awards to be made to a Grantee;

(iii) determine the number of shares of Stock to be subject to an Award;

(iv) establish the terms and conditions of each Award (including, but not limited to, the Option Price of any Option, the nature and duration of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award or the shares of Stock subject thereto, and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options); (v) prescribe the form of each Award Agreement; and

4


 

(vi) amend, modify, or supplement the terms of any outstanding Award including the authority, in order to effectuate the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the United States to recognize differences in local law, tax policy, or custom.

To the extent permitted by applicable law, the Board may delegate its authority as identified herein to any individual or committee of individuals (who need not be directors), including without limitation the authority to make Awards to Grantees who are not subject to Section 16 of the Exchange Act. To the extent that the Board delegates its authority to make Awards as provided by this Section 3.1, all references in the Plan to the Board’s authority to make Awards and determinations with respect thereto shall be deemed to include the Board’s delegate. Any such delegate shall serve at the pleasure of, and may be removed at any time by the Board.

3.2. No Repricing.

Notwithstanding any provision herein to the contrary, the repricing of Options or SARs is prohibited without prior approval of the Company’s shareholders. For this purpose, a “repricing” means any of the following (or any other action that has the same effect as any of the following): (i) changing the terms of an Option or SAR to lower its Option Price or SAR Exercise Price; (ii) any other action that is treated as a “repricing” under generally accepted accounting principles; and (iii) repurchasing for cash or canceling an Option or SAR at a time when its Option Price or SAR Exercise Price is greater than the Fair Market Value of the underlying shares in exchange for another Award, unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under Section 15. A cancellation and exchange under clause (iii) would be considered a “repricing” regardless of whether it is treated as a “repricing” under generally accepted accounting principles and regardless of whether it is voluntary on the part of the Grantee.

3.3. Award Agreements; Clawbacks.

The grant of any Award may be contingent upon the Grantee executing the appropriate Award Agreement. The Company may retain the right in an Award Agreement to cause a forfeiture of all or any part of the gain realized by a Grantee under such Award on account of actions taken by the Grantee in violation or breach of or in conflict with any employment agreement, non-competition agreement, any agreement prohibiting solicitation of employees or clients of the Company or any Subsidiary thereof, any confidentiality obligation with respect to the Company or any Subsidiary thereof or otherwise in competition with the Company or any Subsidiary thereof or any policy of the Company or any Subsidiary thereof. Furthermore, the Company may annul an Award if the Grantee is terminated for “cause” as defined in the applicable Award Agreement.

Awards shall be subject to the requirements of (i) Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (regarding recovery of erroneously awarded compensation) and any implementing rules and regulations thereunder, (ii) similar rules under the laws of any other jurisdiction, (iii) any compensation recovery policies adopted by the Company to implement any such requirements or (iv) any other compensation recovery policies as may be adopted from time to time by the Company, all to the extent determined by the Committee in its discretion to be applicable to a Grantee.

3.4. Deferral Arrangement.

The Board may permit or require the deferral of any Award payment into a deferred compensation arrangement, subject to such rules and procedures as it may establish and in accordance with Section 409A, which may include provisions for the payment or crediting of interest or dividend equivalents, including converting such credits into deferred Stock units.

3.5. Minimum Vesting Period.

All Awards granted under the Plan on or after the First Restatement Effective Date shall be granted with a vesting period of not less than one year from the Grant Date, except for Awards granted with respect to a maximum of five percent of the Shares authorized in the first sentence of Section 4.1.

5


 

3.6. No Liability.

No member of the Board or of the Committee shall be liable for any action or determination made in good faith with respect to the Plan, any Award or Award Agreement.

3.7. Book Entry.

Notwithstanding any other provision of this Plan to the contrary, the Company may elect to satisfy any requirement under this Plan for the delivery of stock certificates through the use of book-entry.

4. STOCK SUBJECT TO THE PLAN

4.1. Authorized Number of Shares.

Subject to adjustment under Section 15, the total number of shares of Common Stock authorized to be awarded under the Plan shall not exceed 4,200,000 shares. In addition, shares of Common Stock underlying any outstanding award granted under the Predecessor Plan that, following the Effective Date, expires, or is terminated, surrendered or forfeited for any reason without issuance of such shares shall be available for the grant of new Awards under this Plan. As provided in Section 1, no new awards shall be granted under the Predecessor Plan following the Effective Date. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares, treasury shares, or shares purchased on the open market or otherwise, all as determined by the Company from time to time.

4.2. Share Counting.

4.2.1 General

Each share of Common Stock granted in connection with an Award shall be counted as one share against the limit in Section 4.1, subject to the provisions of this Section 4.2. Share-based Performance Awards shall be counted assuming maximum performance results (if applicable) until such time as actual performance results can be determined.

4.2.2 Cash-Settled Awards

Any Award settled in cash shall not be counted as shares of Common Stock for any purpose under this Plan.

4.2.3 Expired or Terminated Awards

If any Award under the Plan expires, or is terminated, surrendered or forfeited, in whole or in part, the unissued Common Stock covered by such Award shall again be available for the grant of Awards under the Plan.

4.2.4 Payment of Option Price or Tax Withholding in Shares

The full number of shares of Common Stock with respect to which an Option or SAR is granted shall count against the aggregate number of shares available for grant under the Plan. Accordingly, if in accordance with the terms of the Plan, a Grantee pays the Option Price for an Option by either tendering previously owned shares or having the Company withhold shares, then such shares surrendered to pay the Option Price shall continue to count against the aggregate number of shares available for grant under the Plan set forth in Section 4.1above. In addition, if in accordance with the terms of the Plan, a Grantee satisfies any tax withholding requirement with respect to any taxable event arising as a result of this Plan by either tendering previously owned shares or having the Company withhold shares, then such shares surrendered to satisfy such tax withholding requirements shall continue to count against the aggregate number of shares available for grant under the Plan set forth in Section 4.1 above. Any shares of Common Stock repurchased by the Company with cash proceeds from the exercise of Options shall not be added back to the pool of shares available for grant under the Plan set forth in Section 4.1above.

6


 

4.2.5 Substitute Awards

In the case of any Substitute Award, such Substitute Award shall not be counted against the number of shares reserved under the Plan.

4.3. Award Limits.

4.3.1 Incentive Stock Options

Subject to adjustment under Section 15, 4,200,000 shares of Common Stock available for issuance under the Plan shall be available for issuance as Incentive Stock Options.

4.3.2 Limits on Awards to Non-Employee Directors

No more than $200,000 may be granted in share-based Awards under the Plan during any one year to a Grantee who is a Non-Employee Director (based on (x) the Fair Market Value of the shares of Common Stock underlying the Award as of the applicable Grant Date in the case of Restricted Stock, Restricted Stock Units or Other Stock-based Awards, and (y) the applicable grant date fair value for accounting purposes in the case of Options or SARs). Share-based Awards made to a Grantee who is a Non-Employee Director at such Grantee’s election in lieu of all or a portion of his or her cash retainer or fees for service on the Board and any Board committee shall not be counted towards the limit under this Section 4.3.2.

5. EFFECTIVE DATE, DURATION AND AMENDMENTS

5.1. Term.

The Plan was effective as of the Effective Date’. The Plan shall terminate automatically on the Termination Date and may be terminated on any earlier date as provided in Section 5.2.

5.2. Amendment and Termination of the Plan.

The Board may, at any time and from time to time, amend, suspend, or terminate the Plan as to any Awards which have not been made. An amendment shall be contingent on approval of the Company’s shareholders to the extent stated by the Board, required by applicable law or required by applicable stock exchange listing requirements. Notwithstanding the foregoing, any amendment to Section 3.2 shall be contingent upon the approval of the Company’s shareholders. No Awards shall be made after the Termination Date. The applicable terms of the Plan, and any terms and conditions applicable to Awards granted prior to the Termination Date shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension, or termination of the Plan shall, without the consent of the Grantee, materially impair rights or obligations under any Award previously awarded.

6. AWARD ELIGIBILITY AND LIMITATIONS

6.1. Service Providers.

Subject to this Section 6.1, Awards may be made to any Service Provider as the Board shall determine and designate from time to time in its discretion.

6.2. Successive Awards.

An eligible person may receive more than one Award, subject to such restrictions as are provided herein.

6.3. Stand-Alone, Additional, Tandem, and Substitute Awards.

Awards may, in the discretion of the Board, be granted either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award granted under another plan of the Company, any Subsidiary, or any business entity to be acquired by the Company or its Subsidiary, or any other right of a Grantee to receive payment from the Company or any Subsidiary. Such additional, tandem, and substitute or exchange Awards may be granted at any time. If an Award is granted in substitution or exchange for another Award, the Board shall have the right to require the surrender of such other Award in consideration for the grant of the new Award.

7


 

Subject to Section 3.2, the Board shall have the right, in its discretion, to make Awards in substitution or exchange for any other award under another plan of the Company, any Subsidiary, or any business entity to be acquired by the Company or an Subsidiary. In addition, Awards may be granted in lieu of cash compensation, including in lieu of cash amounts payable under other plans of the Company or any Subsidiary, in which the value of Stock subject to the Award is equivalent in value to the cash compensation (for example, Restricted Stock Units or Restricted Stock).

7. AWARD AGREEMENT

Each Award shall be evidenced by an Award Agreement, in such form or forms as the Board shall from time to time determine. Without limiting the foregoing, an Award Agreement may be provided in the form of a notice which provides that acceptance of the Award constitutes acceptance of all terms of the Plan and the notice. Award Agreements granted from time to time or at the same time need not contain similar provisions but shall be consistent with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be Non-qualified Stock Options or Incentive Stock Options, and in the absence of such specification such options shall be deemed Non-qualified Stock Options.

8. TERMS AND CONDITIONS OF OPTIONS

8.1. Option Price.

The Option Price of each Option shall be fixed by the Board and stated in the related Award Agreement. The Option Price of each Option (except those that constitute Substitute Awards) shall be at least the Fair Market Value on the Grant Date of a share of Stock; provided, however, that in the event that a Grantee is a Ten Percent Shareholder as of the Grant Date, the Option Price of an Option granted to such Grantee that is intended to be an Incentive Stock Option shall be not less than 110 percent of the Fair Market Value of a share of Stock on the Grant Date. In no case shall the Option Price of any Option be less than the par value of a share of Stock.

8.2. Vesting.

Subject to Section 3.5 and Section 8.3 hereof, each Option shall become exercisable at such times and under such conditions (including, without limitation, performance requirements) as shall be determined by the Board and stated in the Award Agreement.

8.3. Term.

Each Option shall terminate, and all rights to purchase shares of Stock thereunder shall cease, upon the expiration of a period not to exceed ten (10) years from the Grant Date, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement; provided, however, that in the event that the Grantee is a Ten Percent Shareholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after the expiration of five (5) years from its Grant Date.

8.4. Limitations on Exercise of Option.

Notwithstanding any other provision of the Plan, in no event may any Option be exercised, in whole or in part, (i) prior to the date the Plan is approved by the shareholders of the Company as provided herein or (ii) after the occurrence of an event which results in termination of the Option.

8.5. Method of Exercise.

An Option that is exercisable may be exercised by the Grantee’s delivery of a notice of exercise to the Company, setting forth the number of shares of Stock with respect to which the Option is to be exercised, accompanied by full payment for the shares. To be effective, notice of exercise must be made in accordance with procedures established by the Company from time to time.

8


 

8.6. Rights of Holders of Options.

Unless otherwise stated in the related Award Agreement, an individual holding or exercising an Option shall have none of the rights of a shareholder (for example, the right to receive cash or dividend payments or distributions attributable to the subject shares of Stock or to direct the voting of the subject shares of Stock) until the shares of Stock covered thereby are fully paid and issued to him. Except as provided in Section 15 hereof or the related Award Agreement, no adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date of such issuance.

8.7. Limitations on Incentive Stock Options.

An Option shall constitute an Incentive Stock Option only (i) if the Grantee of such Option is an employee of the Company or any Subsidiary of the Company; (ii) to the extent specifically provided in the related Award Agreement; and (iii) to the extent that the aggregate Fair Market Value (determined at the time the Option is granted) of the shares of Stock with respect to which all Incentive Stock Options held by such Grantee become exercisable for the first time during any calendar year (under the Plan and all other plans of the Grantee’s employer and its Affiliates) does not exceed $100,000. This limitation shall be applied by taking Options into account in the order in which they were granted.

9. TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS

9.1. Right to Payment.

A SAR shall confer on the Grantee a right to receive, upon exercise thereof, the excess of (i) the Fair Market Value of one share of Stock on the date of exercise over (ii) the SAR Exercise Price, as determined by the Board. The Award Agreement for a SAR (except those that constitute Substitute Awards) shall specify the SAR Exercise Price, which shall be fixed on the Grant Date as not less than the Fair Market Value of a share of Stock on that date. SARs may be granted alone or in conjunction with all or part of an Option or at any subsequent time during the term of such Option or in conjunction with all or part of any other Award. A SAR granted in tandem with an outstanding Option following the Grant Date of such Option shall have a SAR Exercise Price that is equal to the Option Price; provided, however, that the SAR Exercise Price may not be less than the Fair Market Value of a share of Stock on the Grant Date of the SAR to the extent required by Section 409A.

9.2. Other Terms.

The Board shall determine at the Grant Date, subject to Section 3.5 hereof the time or times at which and the circumstances under which a SAR may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), the time or times at which SARs shall cease to be or become exercisable following Separation from Service or upon other conditions, the method of exercise, whether or not a SAR shall be in tandem or in combination with any other Award, and any other terms and conditions of any SAR.

9.3. Rights of Holders of SARs.

An individual holding or exercising an SAR shall have none of the rights of a shareholder (for example, the right to receive cash or dividend payments or distributions attributable to the subject shares of Stock or to direct the voting of the subject shares of Stock). Except as provided in Section 15 hereof or the related Award Agreement, no adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date of such issuance.

9.4. Term of SARs.

The term of a SAR granted under the Plan shall be determined by the Board, in its sole discretion; provided, however, that such term shall not exceed ten (10) years.

9.5. Payment of SAR Amount.

Upon exercise of a SAR, a Grantee shall be entitled to receive payment from the Company (in cash or Stock, as determined by the Board) in an amount determined by multiplying:

9


 

(i) the difference between the Fair Market Value of a share of Stock on the date of exercise over the SAR Exercise Price; by

(ii) the number of shares of Stock with respect to which the SAR is exercised.

10. TERMS AND CONDITIONS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS

10.1. Restrictions.

At the time of grant, the Board may, in its sole discretion, establish a period of time (a “Restriction Period”) and any additional restrictions including the satisfaction of corporate or individual performance objectives applicable to an Award of Restricted Stock or Restricted Stock Units in accordance with Section 12.1 and 12.2. Subject to Section 3.5hereof, each Award of Restricted Stock or Restricted Stock Units may be subject to a different Restriction Period and additional requirements as determined by the Board. Neither Restricted Stock nor Restricted Stock Units may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the Restriction Period or prior to the satisfaction of any other applicable restrictions.

10.2. Restricted Stock Certificates.

The Company shall issue stock, in the name of each Grantee to whom Restricted Stock has been granted, stock certificates or other evidence of ownership representing the total number of shares of Restricted Stock granted to the Grantee, as soon as reasonably practicable after the Grant Date.

10.3. Rights of Holders of Restricted Stock.

Unless the Board otherwise provides in an Award Agreement and subject to Section 17.12, holders of Restricted Stock shall have all rights as shareholders of the Company, including voting and dividend rights.

10.4. Rights of Holders of Restricted Stock Units.

10.4.1 Settlement of Restricted Stock Units

Restricted Stock Units may be settled in cash or Stock, as determined by the Board and set forth in the Award Agreement. The Award Agreement shall also set forth whether the Restricted Stock Units shall be settled (i) within the time period specified for “short term deferrals” under Section 409A or (ii) otherwise within the requirements of Section 409A, in which case the Award Agreement shall specify upon which events such Restricted Stock Units shall be settled.

10.4.2 Voting and Dividend Rights

Unless otherwise stated in the applicable Award Agreement and subject to Section 17.12, holders of Restricted Stock Units shall not have rights as shareholders of the Company, including no voting or dividend or dividend equivalents rights.

10.4.3 Creditor’s Rights

A holder of Restricted Stock Units shall have no rights other than those of a general creditor of the Company. Restricted Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Award Agreement.

10.5. Purchase of Restricted Stock.

The Grantee shall be required, to the extent required by applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater of (i) the aggregate par value of the shares of Stock represented by such Restricted Stock or (ii) the Purchase Price, if any, specified in the related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by Services already rendered. The Purchase Price shall be payable in a form described in Section 11 or, in the discretion of the Board and subject to Section 409A, in consideration for past Services rendered.

10


 

10.6. Delivery of Stock.

Upon the expiration or termination of any Restriction Period and the satisfaction of any other conditions prescribed by the Board, the restrictions applicable to shares of Restricted Stock or Restricted Stock Units settled in Stock shall lapse, and, unless otherwise provided in the Award Agreement, a stock certificate for such shares shall be delivered, free of all such restrictions, to the Grantee or the Grantee’s beneficiary or estate, as the case may be.

11. FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK

11.1. General Rule.

Payment of the Option Price for the shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be made in cash or in cash equivalents acceptable to the Company, except as provided in this Section 11.

11.2. Surrender of Stock.

To the extent the Award Agreement so provides, payment of the Option Price for shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock may be made all or in part through the tender to the Company of shares of Stock, which shares shall be valued, for purposes of determining the extent to which the Option Price or Purchase Price for Restricted Stock has been paid thereby, at their Fair Market Value on the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment in the form of already owned shares of Stock may be authorized only at the time of grant.

11.3.Cashless Exercise.

With respect to an Option only (and not with respect to Restricted Stock), to the extent permitted by law and to the extent the Award Agreement so provides, payment of the Option Price may be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction to a licensed securities broker acceptable to the Company to sell shares of Stock and to deliver all or part of the sales proceeds to the Company in payment of the Option Price and any withholding taxes described in Section 17.3.

11.4. Other Forms of Payment.

To the extent the Award Agreement so provides, payment of the Option Price or the Purchase Price for Restricted Stock may be made in any other form that is consistent with applicable laws, regulations and rules, including, but not limited to, the Company’s withholding of shares of Stock otherwise due to the exercising Grantee.

12. TERMS AND CONDITIONS OF PERFORMANCE AWARDS

12.1. Performance Conditions.

The right of a Grantee to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such performance conditions as may be specified by the Committee. The Committee may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance conditions.

12.2. Performance Awards Granted Under Prior Section 162(m).

Notwithstanding anything to the contrary herein, no provision of the Plan is intended to result in non-deductibility of Awards that were intended to be deductible in accordance with Prior Section 162(m). The Company intends to avail itself of transition relief applicable to such Awards, if any, in connection with Section 162(m) of the Code (including, without limitation, in accordance with the Section 162(m) Grandfather) to the maximum extent permitted by regulations and other guidance promulgated to implement such transition relief. The determination by the Company regarding whether transition relief is available shall be made in its discretion.

11


 

13. OTHER STOCK-BASED AWARDS

13.1. Grant of Other Stock-based Awards.

Other Stock-based Awards may be granted either alone or in addition to or in conjunction with other Awards under the Plan. Other Stock-based Awards may be granted in lieu of other cash or other compensation to which a Service Provider is entitled from the Company or may be used in the settlement of amounts payable in shares of Common Stock under any other compensation plan or arrangement of the Company. Subject to the provisions of the Plan, the Committee shall have the sole and complete authority to determine the persons to whom and the time or times at which such Awards shall be made, the number of shares of Common Stock to be granted pursuant to such Awards, and, subject to Section 3.5 hereof, all other conditions of such Awards. Unless the Committee determines otherwise, any such Award shall be confirmed by an Award Agreement, which shall contain such provisions as the Committee determines to be necessary or appropriate to carry out the intent of this Plan with respect to such Award.

13.2. Terms of Other Stock-based Awards.

Any Common Stock subject to Awards made under this Section 13 may not be sold, assigned, transferred, pledged or otherwise encumbered prior to the date on which the shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.

13.3. Rights of Holders of Other Stock-based Awards.

Unless the Board otherwise provides in an Award Agreement and subject to Section 17.12, holders of Other Stock-based Awards shall have rights as shareholders of the Company, including voting and dividend rights.

14. REQUIREMENTS OF LAW

14.1. General.

The Company shall not be required to sell or issue any shares of Stock under any Award if the sale or issuance of such shares would constitute a violation by the Grantee, any other individual exercising an Option, or the Company of any provision of any law or regulation of any governmental authority, including without limitation any federal or state securities laws or regulations. If at any time the Company shall determine, in its discretion, that the listing, registration or qualification of any shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issuance or purchase of shares hereunder, no shares of Stock may be issued or sold to the Grantee or any other individual exercising an Option pursuant to such Award unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act, upon the exercise of any Option or the delivery of any shares of Stock underlying an Award, unless a registration statement under such Act is in effect with respect to the shares of Stock covered by such Award, the Company shall not be required to sell or issue such shares unless the Board has received evidence satisfactory to it that the Grantee or any other individual exercising an Option may acquire such shares pursuant to an exemption from registration under the Securities Act. Any determination in this connection by the Board shall be final, binding, and conclusive. The Company may, but shall in no event be obligated to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of shares of Stock pursuant to the Plan to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable until the shares of Stock covered by such Option are registered or are exempt from registration, the exercise of such Option (under circumstances in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability of such an exemption.

14.2. Rule 16b-3.

During any time when the Company has a class of equity security registered under Section 12 of the Exchange Act, it is the intent of the Company that Awards and the exercise of Options granted to officers and directors hereunder will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision of the Plan or action by the Board or Committee does not comply with the requirements of Rule 16b-3, it shall be deemed inoperative to the extent permitted by law and deemed advisable by the Board, and shall not affect the validity of the Plan.

12


 

In the event that Rule 16b-3 is revised or replaced, the Board may exercise its discretion to modify this Plan in any respect necessary to satisfy the requirements of, or to take advantage of any features of, the revised exemption or its replacement.

15. EFFECT OF CHANGES IN CAPITALIZATION

15.1. Changes in Stock.

If (i) the number of outstanding shares of Stock is increased or decreased or the shares of Stock are changed into or exchanged for a different number or kind of shares or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of shares, stock dividend or other distribution payable in capital stock, or other increase or decrease in such shares effected without receipt of consideration by the Company occurring after the Effective Date or (ii) there occurs any spin-off, split-up, extraordinary cash dividend or other distribution of assets by the Company, the number and kinds of shares for which grants of Awards may be made under the Plan (including the per-Grantee maximums set forth in Section 4) shall be equitably adjusted by the Company; provided that any such adjustment shall comply with Section 409A. In addition, in the event of any such increase or decrease in the number of outstanding shares or other transaction described in clause (ii) above, the number and kind of shares for which Awards are outstanding and the Option Price per share of outstanding Options and SAR Exercise Price per share of outstanding SARs shall be equitably adjusted; provided that any such adjustment shall comply with Section 409A.

15.2. Effect of Certain Transactions.

Except as otherwise provided in an Award Agreement, in the event of a Corporate Transaction, the Plan and the Awards issued hereunder shall continue in effect in accordance with their respective terms, except that following a Corporate Transaction either (i) each outstanding Award shall be treated as provided for in the agreement entered into in connection with the Corporate Transaction or (ii) if not so provided in such agreement, each Grantee shall be entitled to receive in respect of each share of Common Stock subject to any outstanding Awards, upon exercise or payment or transfer in respect of any Award, the same number and kind of stock, securities, cash, property or other consideration that each holder of a share of Common Stock was entitled to receive in the Corporate Transaction in respect of a share of Common Stock; provided, however, that, unless otherwise determined by the Committee, such stock, securities, cash, property or other consideration shall remain subject to all of the conditions, restrictions and performance criteria which were applicable to the Awards prior to such Corporate Transaction. Without limiting the generality of the foregoing, the treatment of outstanding Options and SARs pursuant to this Section 15.2 in connection with a Corporate Transaction in which the consideration paid or distributed to the Company’s shareholders is not entirely shares of Common Stock of the acquiring or resulting corporation may include the cancellation of outstanding Options and SARs upon consummation of the Corporate Transaction as long as, at the election of the Committee, (i) the holders of affected Options and SARs have been given a period of at least fifteen days prior to the date of the consummation of the Corporate Transaction to exercise the Options or SARs (to the extent otherwise exercisable) or (ii) the holders of the affected Options and SARs are paid (in cash or cash equivalents) in respect of each Share covered by the Option or SAR being canceled an amount equal to the excess, if any, of the per share price paid or distributed to shareholders in the Corporate Transaction (the value of any non-cash consideration to be determined by the Committee in its sole discretion) over the Option Price or SAR Exercise Price, as applicable. For avoidance of doubt, (1) the cancellation of Options and SARs pursuant to clause (ii) of the preceding sentence may be effected notwithstanding anything to the contrary contained in this Plan or any Award Agreement and (2) if the amount determined pursuant to clause (ii) of the preceding sentence is zero or less, the affected Option or SAR may be cancelled without any payment therefore. The treatment of any Award as provided in this Section 15.2 shall be conclusively presumed to be appropriate for purposes of Section 15.1.

15.3. Change in Control.

15.3.1 Consequences of a Change in Control

For any Awards outstanding as of the date of a Change in Control, either of the following provisions shall apply, depending on whether, and the extent to which, Awards are assumed, converted or replaced by the resulting entity in a Change in Control, unless otherwise provided by the Award Agreement:

13


 

(i) To the extent such Awards are not assumed, converted or replaced by the resulting entity in the Change in Control, then upon the Change in Control such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance Awards, shall lapse and become vested and non-forfeitable, and for any outstanding Performance Awards the target payout opportunities attainable under such Awards shall be deemed to have been fully earned as of the Change in Control based upon the greater of: (A) an assumed achievement of all relevant performance goals at the “target” level, or (B) the actual level of achievement of all relevant performance goals against target as of the Company’s fiscal quarter end preceding the Change in Control and the Award shall become vested pro rata based on the portion of the applicable performance period completed through the date of the Change in Control.

(ii) To the extent such Awards are assumed, converted or replaced by the resulting entity in the Change in Control, if, within two years after the date of the Change in Control, the Service Provider has a Separation from Service by the Company other than for “cause” (which may include a Separation from Service by the Service Provider for “good reason” if provided in the applicable Award Agreement), as such terms are defined in the Award Agreement, then such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance Awards, shall lapse and become vested and non-forfeitable, and for any outstanding Performance Awards the target payout opportunities attainable under such Awards shall be deemed to have been fully earned as of the Separation from Service based upon the greater of: (A) an assumed achievement of all relevant performance goals at the “target” level, or (B) the actual level of achievement of all relevant performance goals against target as of the Company’s fiscal quarter end preceding the Change in Control and the Award shall become vested pro rata based on the portion of the applicable performance period completed through the date of the Separation from Service.

15.3.2 Change in Control Defined

Except as may otherwise be defined in an Award Agreement, a “Change in Control” shall mean the occurrence of any of the following events:

(a) The acquisition in one or more transactions, other than from the Company, by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act), other than the Company, a Subsidiary or any employee benefit plan (or related trust) sponsored or maintained by the Company or a Subsidiary, of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of a number of the Company’s Voting Securities in excess of 50% of the Company’s Voting Securities unless such acquisition has been approved by the Board;

(b) Any election has occurred of persons to the Board that causes the Board to consist of members, of which fewer than two thirds are (i) persons who were members of the Board on the Effective Date of the Plan and (ii) persons who were nominated for elections as members of the Board at a time when two-thirds of the Board consisted of persons who were members of the Board on the Effective Date of the Plan, provided, however, that any person nominated for election by a Board at least two-thirds of whom constituted persons described in clauses (i) and/or (ii) or by persons who were themselves nominated by such Board shall, for this purpose, be deemed to have been nominated by a Board composed of persons described in clause (i);

(c) The consummation (i.e. closing) of a reorganization, merger or consolidation involving the Company, unless, following such reorganization, merger or consolidation, all or substantially all of the individuals and entities who were the respective beneficial owners of the Outstanding Common Stock and the Company’s Voting Securities immediately prior to such reorganization, merger or consolidation, following such reorganization, merger or consolidation beneficially own, directly or indirectly, more than 75% of, respectively, the then outstanding shares of Common Stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors or trustees, as the case may be, of the entity resulting from such reorganization, merger or consolidation in substantially the same proportion as their ownership of the Outstanding Common Stock and the Company’s Voting Securities immediately prior to such reorganization, merger or consolidation, as the case may be;

(d) The consummation (i.e. closing) of a sale or other disposition of all or substantially all the assets of the Company, unless, following such sale or disposition, all or substantially all of the individuals and entities who were the respective beneficial owners of the Outstanding Common Stock and the Company’s Voting Securities immediately prior to such sale or disposition, following such sale or disposition beneficially own, directly or indirectly, more than 75% of, respectively, the then outstanding shares of Common Stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors or trustees, as the case may be, of the entity purchasing such assets in substantially the same proportion as their ownership of the Outstanding Common Stock and the Company’s Voting Securities immediately prior to such sale or disposition, as the case may be; or

14


 

(e) a complete liquidation or dissolution of the Company.

Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and payable upon a Change in Control, the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a “change in control event” pursuant to the definition of such term in Section 409A.

15.4. Adjustments.

Adjustments under this Section 15 related to shares of Stock or securities of the Company shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. No fractional shares or other securities shall be issued pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole share.

16. NO LIMITATIONS ON COMPANY

The making of Awards pursuant to the Plan shall not affect or limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business or assets.

17. TERMS APPLICABLE GENERALLY TO AWARDS GRANTED UNDER THE PLAN

17.1. Disclaimer of Rights.

No provision in the Plan or in any Award Agreement shall be construed to confer upon any individual the right to remain in the employ or service of the Company or any Subsidiary, or to interfere in any way with any contractual or other right or authority of the Company either to increase or decrease the compensation or other payments to any individual at any time, or to terminate any employment or other relationship between any individual and the Company. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise stated in the applicable Award Agreement, no Award granted under the Plan shall be affected by any change of duties or position of the Grantee, so long as such Grantee continues to be a Service Provider. The obligation of the Company to pay any benefits pursuant to this Plan shall be interpreted as a contractual obligation to pay only those amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary under the terms of the Plan.

17.2. Nonexclusivity of the Plan.

Neither the adoption of the Plan nor the submission of the Plan to the shareholders of the Company for approval shall be construed as creating any limitations upon the right and authority of the Board to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to a particular individual or particular individuals), including, without limitation, the granting of stock options as the Board in its discretion determines desirable.

17.3. Withholding Taxes.

The Company or an Subsidiary, as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state, or local taxes of any kind required by law to be withheld (i) with respect to the vesting of or other lapse of restrictions applicable to an Award, (ii) upon the issuance of any shares of Stock upon the exercise of an Option or SAR, or (iii) otherwise due in connection with an Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay to the Company or the Subsidiary, as the case may be, any amount that the Company or the Subsidiary may reasonably determine to be necessary to satisfy such withholding obligation. The Company or the Subsidiary, as the case may be, may in its sole discretion, require or permit the Grantee to satisfy such obligations, in whole or in part, (i) by causing the Company or the Subsidiary to withhold the minimum required number of shares of Stock otherwise issuable to the Grantee as may be necessary to satisfy such withholding obligation or (ii) by delivering to the Company or the Subsidiary shares of Stock already owned by the Grantee.

15


 

The shares of Stock so delivered or withheld shall have an aggregate Fair Market Value equal to such withholding obligations. The Fair Market Value of the shares of Stock used to satisfy such withholding obligation shall be determined by the Company or the Subsidiary as of the date that the amount of tax to be withheld is to be determined. To the extent applicable, a Grantee may satisfy his or her withholding obligation only with shares of Stock that are not subject to any repurchase, forfeiture, unfulfilled vesting, or other similar requirements.

17.4. Captions.

The use of captions in this Plan or any Award Agreement is for the convenience of reference only and shall not affect the meaning of any provision of the Plan or any Award Agreement.

17.5. Other Provisions.

Each Award Agreement may contain such other terms and conditions not inconsistent with the Plan as may be determined by the Board, in its sole discretion. In the event of any conflict between the terms of any employment agreement and the Plan, the terms of the employment agreement govern.

17.6. Number and Gender.

With respect to words used in this Plan, the singular form shall include the plural form, the masculine gender shall include all forms of gender identity, as the context requires.

17.7. Severability.

If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.

17.8. Governing Law.

The Plan shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without giving effect to the principles of conflicts of law, and applicable federal law.

17.9. Section 409A.

The Plan is intended to comply with Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in Section 409A shall not be treated as deferred compensation unless applicable laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6) month period immediately following the Grantee’s Separation from Service shall instead be paid on the first payroll date after the six-month anniversary of the Grantee’s Separation from Service (or the Grantee’s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Grantee under Section 409A and neither the Company nor the Committee will have any liability to any Grantee for such tax or penalty.

17.10. Separation from Service.

The Board shall determine the effect of a Separation from Service upon Awards, and such effect shall be set forth in the appropriate Award Agreement. Without limiting the foregoing, the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Grantee, the actions that will be taken upon the occurrence of a Separation from Service, including, but not limited to, death, disability, accelerated vesting or termination, depending upon the circumstances surrounding the Separation from Service.

16


 

17.11. Transferability of Awards.

17.11.1 Transfers in General

Except as provided in Section 17.11.2, no Award shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution, and, during the lifetime of the Grantee, only the Grantee personally (or the Grantee’s personal representative) may exercise rights under the Plan.

17.11.2 Family Transfers

If authorized in the applicable Award Agreement, a Grantee may transfer, not for value, all or part of an Award (other than Incentive Stock Options) to any Family Member. For the purpose of this Section 17.11.2, a “not for value” transfer is a transfer which is (i) a gift, (ii) a transfer under a domestic relations order in settlement of marital property rights; or (iii) a transfer to an entity in which more than fifty percent of the voting interests are owned by Family Members (or the Grantee) in exchange for an interest in that entity. Following a transfer under this Section 17.11.2, any such Award shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. Subsequent transfers of transferred Awards are prohibited except to Family Members of the original Grantee in accordance with this Section 17.11.2 or by will or the laws of descent and distribution.

17.12. Dividends and Dividend Equivalent Rights.

If specified in the Award Agreement, the recipient of an Award under this Plan may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents with respect to the Common Stock or other securities covered by an Award. The terms and conditions of a dividend equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Grantee may be paid currently or may be deemed to be reinvested in additional shares of Stock or other securities of the Company at a price per unit equal to the Fair Market Value of a share of Stock on the date that such dividend was paid to shareholders, as determined in the sole discretion of the Committee. Notwithstanding the foregoing, in no event will dividends or dividend equivalents on any Award which is subject to vesting requirements or the achievement of performance criteria be paid before the Award has become earned and payable.

17


EX-31.1 3 ap-ex31_1.htm PRINCIPAL EXECUTIVE OFFICER SECTION 302 EX-31.1

Exhibit 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, J. Brett McBrayer, certify that:

1.
I have reviewed this Form 10-Q of Ampco-Pittsburgh Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

 

/s/ J. Brett McBrayer

J. Brett McBrayer

Director and Chief Executive Officer

May 12, 2025

 


EX-31.2 4 ap-ex31_2.htm PRINCIPAL FINANCIAL OFFICER SECTION 302 EX-31.2

Exhibit 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Michael G. McAuley, certify that:

1.
I have reviewed this Form 10-Q of Ampco-Pittsburgh Corporation;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

 

 

/s/ Michael G. McAuley

Michael G. McAuley

Senior Vice President, Chief Financial Officer and Treasurer

May 12, 2025

 

 


EX-32.1 5 ap-ex32_1.htm PRINCIPAL EXECUTIVE OFFICER SECTION 906 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ampco-Pittsburgh Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

 

 

 

/s/ J. Brett McBrayer

J. Brett McBrayer

Director and Chief Executive Officer

May 12, 2025

 


EX-32.2 6 ap-ex32_2.htm PRINCIPAL FINANCIAL OFFICER SECTION 906 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ampco-Pittsburgh Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2025 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

 

 

 

/s/ Michael G. McAuley

Michael G. McAuley

Senior Vice President, Chief Financial Officer and

Treasurer

May 12, 2025